WO1998018904A1 - Method for separating and concentrating small molecules using enzymatic membrane pumps: separator/concentrator reactor - Google Patents

Method for separating and concentrating small molecules using enzymatic membrane pumps: separator/concentrator reactor Download PDF

Info

Publication number
WO1998018904A1
WO1998018904A1 PCT/FR1997/001936 FR9701936W WO9818904A1 WO 1998018904 A1 WO1998018904 A1 WO 1998018904A1 FR 9701936 W FR9701936 W FR 9701936W WO 9818904 A1 WO9818904 A1 WO 9818904A1
Authority
WO
WIPO (PCT)
Prior art keywords
membrane
pac
compartment
enzymatic
liquid
Prior art date
Application number
PCT/FR1997/001936
Other languages
French (fr)
Inventor
Bernard Maisterrena
Original Assignee
Universite Claude Bernard Lyon I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Claude Bernard Lyon I filed Critical Universite Claude Bernard Lyon I
Priority to AU49526/97A priority Critical patent/AU4952697A/en
Publication of WO1998018904A1 publication Critical patent/WO1998018904A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00Bioreactors or fermenters specially adapted for specific uses
    • C12M21/18Apparatus specially designed for the use of free, immobilized or carrier-bound enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M29/00Means for introduction, extraction or recirculation of materials, e.g. pumps
    • C12M29/04Filters; Permeable or porous membranes or plates, e.g. dialysis

Definitions

  • the field of the present invention is that of the separation and over-concentration of small molecules in the liquid phase, by passage through a porous bioactive membrane. In other words, it is the active transport of certain solutes that one seeks to isolate and / or to over-concentrate.
  • the invention refers to the techniques of purification / separation / concentration of molecules - generally small - and present in liquid media in the trace state.
  • Such highly diluted molecules may be advantageous to purify or to isolate either because they have a high added value, for example in the pharmaceutical industry, or because they constitute an undesirable polluting load in these liquid media, or because they are below the analytical detection threshold.
  • Dialysis is also known by passive diffusion of solute through a porous membrane. Dialysis is only effective for molecules present in significant quantities on one side of the membrane and capable of crossing the latter under the effect of a concentration gradient. It is clear that dialysis does not allow molecules that are present in trace amounts to be over-concentrated in a liquid on the other side of the membrane. It is therefore necessary to note the deficiency, in the state of the art, in means of over-concentration of small molecules (Molecular Weight ⁇ 1000 Daltons) present in liquid media - more particularly in very small quantities - and whose over-concentration is exploitable: in recovery when it comes to molecules with high added value (chemical and / or pharmaceutical),
  • one of the essential objectives of the present invention is to remedy this deficiency, by providing a process for the separation and concentration of at least one Pac concentrating product, present in a liquid medium in dissolved form. More specifically, the aim of this process would be to migrate the Pac Product from a starting compartment of the liquid medium weakly concentrated in Pac, to another compartment arriving from the liquid medium, in which it would accumulate in such a way that its concentration in said arrival compartment increases.
  • Another essential objective of the invention is to provide a process of separation / over-concentration of one or more solutes, which is selective and which makes it possible to obtain a pure or substantially pure “over-concentrate”.
  • Another essential objective of the present invention is to provide a method of separation / over-concentration of at least one Pac solute, leading to over-concentration ratios from a departure compartment to an arrival compartment, clearly greater than 1.
  • Another essential objective of the invention is to provide a separation / over-concentration process for a Pac solute, which is simple to implement and economical.
  • Another essential objective of the present invention is to provide a device for separating and concentrating at least one Pac concentrating product, present in a liquid medium in dissolved form, in particular for implementing the method as mentioned above.
  • the inventor had the merit of highlighting, after long and painstaking research and experiments, the fact that it was possible to implement an active transport system of a Pac solute, from a starting liquid compartment to another incoming liquid compartment, by enzymatic pumping through a porous membrane.
  • This principle highlighted by the inventor is based on the intervention of a pair of reversible enzymes, one of the pair's enzymes being fixed on one side of the porous membrane and the other enzyme on the opposite side of said membrane.
  • the product or the substrate linked to this pair of enzymes is loaded with a sign that is either opposite or identical to that of at least one of the faces of the membrane.
  • the transfer of a Pac compound is carried out in fact through its enzymatic transformation product by one of the enzymes of the couple used. Throughout this presentation, this transformation product will be referred to as a “migratory intermediary”. If the migratory intermediate is charged, then the membrane will be of an opposite sign so as to favor the transmembrane diffusion of this charged product. If the migrating intermediate is not loaded, then the membrane is loaded with the same sign as the Pac compound which one seeks to over-concentrate, so as to produce a valve effect opposing the return of the Pac product in the departure compartment.
  • the present invention relates to a simultaneous process for the separation and concentration of at least one Concentrated Product (PAC), present in a liquid medium in solubilized form, characterized in that it consists essentially and successively or not : - to select at least one pair of reversible enzymes E j / E 2 ,
  • PAC Concentrated Product
  • E j being able to catalyze the reaction of transformation of at least one substrate A into at least one product B and E 2 the reverse reaction of transformation of the substrate (s) B into at least one product A:
  • each membrane delimiting at least in part at least one liquid compartment C, and at least one liquid compartment C ⁇ ,
  • each membrane is charged with the opposite sign on at least one of its faces, preferably this adjacent to the face carrying the enzyme having transformed the Pac,
  • each membrane is electrically charged with the same sign as the other non-metabolized and non-migrating compound A or B (Pac),
  • Such an enzymatic pumping process is particularly advantageous since it allows a selective over-concentration of one or more Pac solutes, and this without excessive energy consumption, unlike the system of over-concentration by overpressure. Indeed, this enzymatic pump essentially only requires chemical energy, which can be provided for example by molecules with an energy-rich bond, such as adenosine triphosphate (ATP).
  • Another advantage of the method according to the invention is to lead to an over-concentration of Pac in relatively pure form, that is to say unpolluted by the migratory intermediate.
  • the new and innovative approach according to the invention therefore consisted, firstly, of understanding and explaining the biological phenomenon and, secondly, of reproducing it (mimicry) by adapting it to the industrial specifications of separation / over-concentration of chemical compounds, in particular for recovery of molecules with high added value: chemical, pharmaceutical, cosmetic or other, for the purpose of elimination and isolation of toxic compounds, or even for the purpose of lowering thresholds analytical detection so as to make analyzes possible.
  • E X IE 2 a pair of reversible enzymes capable of forming the enzymatic pump allowing the transfer of Pac, via its enzymatic transformation product with E, or E 2 .
  • the electrically charged nature of at least one of the product / substrate A and B of E, / E 2 is another essential condition of the invention, knowing that - Compound A or B, useful as a transmembrane migratory intermediate, is neutral or has a charge opposite to that existing on the faces of the membrane; and that the Pac compound is neutral or has an electrical charge of the same sign as that existing on at least one of the faces of the membrane.
  • the electrical charge of the faces of the porous membrane can be obtained for example, by immobilizing with E j and E 2 polyamino acids, the pK of which give the membrane, for a given pH, negative or positive charges.
  • the polyamino acid is eg polylysine
  • the membrane is positively charged at pH 9
  • a polyamino acid corresponding eg to a polyglutamate the membrane is negatively charged at pH 9.
  • membranes whose zeta potential at optimum pH is adapted to given conditions of the process of the invention.
  • This porous membrane must be arranged in such a way that it delimits at least in part, once immersed in the liquid medium, at least one compartment C, - preferably one - and at least one compartment C ⁇ - preferably one.
  • the compartment C x or C ⁇ from the start of the PAC has a volume greater than that of the compartment C fatigueor C, for arrival.
  • volume of C, or II of arrival / V of C ⁇ or, of departure must be as low as possible, this ratio playing on the kinetics of transport (but not on the final report of over-concentration).
  • the active transmembrane transport according to the invention passes by the exploitation of a first effect which one can call “flapper effect” and / or a second effect which can be called the effect of promoting the dissemination of the migratory intermediary.
  • the valve effect is obtained by ensuring that the Pac, the migration of which it is desired to limit through the membrane, is of a sign opposite to the latter, so as to be repelled by it and thus not having tendency to cross it.
  • the invention is not limited to the implementation of only one of these effects. It is entirely possible to predict their cumulation.
  • the enzymatic membrane is in the form of a monolayer or multilayer film, preferably substantially planar.
  • This discontinuous mode corresponds for example to the case in which there is a reactor formed by a first container containing the liquid medium in which a second container is at least partially immersed.
  • the submerged part of this second container being constituted at least in part by the porous enzymatic membrane.
  • the membrane can form all or part of the wall of the container.
  • this membrane constitutes a substantially planar part of the partition wall between the two compartments C j and C ⁇ .
  • the enzymatic membrane is in the form tubular and more precisely constitutes all or part of the wall of a tube, the lumen of which forms one of the compartments C j / C u .
  • the enzymatic membrane can be made of a plurality of hollow fibers or tubular membranes, preferably united in a bundle (x).
  • this (or these) tubular membrane (s) is immersed in the liquid medium forming the other compartment Ci C, and a liquid is circulated to be enriched or deplete the Pac compound in this (or these) tubular enzymatic membrane (s).
  • the pH and temperature parameters of the liquid media are adjusted, so as to obtain an optimum in kinetics and in yield for the enzymatic transformations by E, and E 2 .
  • the liquid medium of C and / or Cn is therefore prepared by using a solvent - preferably essentially aqueous - optionally comprising solutes chosen from the following group: o pH buffers adapted to the optimum operating pH of E, and E 2 , o molecules with energy-rich bonds - advantageously ATP or any molecule capable of transferring a phosphate group onto a solute (for example: phosphoenol pyruvate, carbamyl phosphate, phosphocreatine ...) o and their mixtures, the compositions starting from the liquid media of C j and C, j being preferably substantially the same or not of the Pac concentration.
  • a solvent - preferably essentially aqueous - optionally comprising solutes chosen from the following group: o pH buffers adapted to the optimum operating pH of E, and E 2 , o molecules with energy-rich bonds - advantageously ATP or any molecule capable of transferring a phosphate group onto a solute (for example:
  • the temperature of the liquid media is also regulated by adding or removing calories, eg thermostatically controlled reactor with double wall for circulation of temperature-regulating fluid.
  • the compartment C, / C ⁇ , receiver of the migratory intermediate through the membrane initially comprises a concentration of this intermediate, lower than that existing in the transmitting compartment.
  • the diffusion layers are obtained by setting in motion the liquid in each compartment C, / C ⁇ , this setting in motion being effected by stirring - preferably using a rotor - in the first mode of implementation according to the invention and / or by circulation of said liquid according to the second mode of implementation of the method according to the invention.
  • the stirring and / or circulation conditions are adjusted so that the non-turbulent diffusion layer or layers have an identical or different thickness on either side of the membrane and between 1 and 10 times the thickness of the membrane.
  • auxiliary means of assistance for transmembrane migration of (or of) migratory intermediary (ies) said means preferably being constituted by a gradient of ionic and / or electrical force, on either side of the membrane, and more preferably still by pH gradients (protomotor force).
  • the overconcentration of the Pac is supplemented by enzymatic pumping of the said Pac through the membrane (s) from a compartment C, or C Facecontaining Pac to a compartment Cn or C, to be enriched with Pac, by implementing a translocation of Pac, the latter consisting in introducing into the starting compartment C ] or C ⁇ loaded with Pac, the migrating intermediate A or B of enzymatic transformation - 1 - of the Pac by E j or E 2 , so that this added migratory intermediary migrates cumulatively to that from stage - 1 -, under the same conditions as those of stage - 2 -, to be finally subjected to stage 3 after having crossed the membrane, stages - 1 -, - 2 - , and - 3 - at issue being those as defined above.
  • the present invention also relates to a device for separating and concentrating at least one Concentrated Product (PAC), present in a liquid medium in solubilized form, in particular for implementing the method as defined above, characterized in what it basically includes:
  • At least one porous enzymatic membrane comprising at least a pair of reversible enzymes E l IE 2 , E, being able to catalyze the reaction of transformation of at least one substrate A into at least one product B and E 2 the reaction reverse of transformation of the substrate (s) B into at least one product
  • each membrane is electrically charged, on at least one of its faces, preferably on that adjacent to the face carrying the enzyme which has transformed the Pac, and more preferably still on both.
  • this enzymatic membrane is a porous matrix, in and / or on the two faces of which are included and immobilized the enzymes Ei, E 2 respectively, this matrix being formed by at least one macromolecular compound , preferably chosen from proteins, polysaccharides, synthetic (co) polymers and their mixtures and / or alloys, etc., these compounds being chosen for their porosity, thickness, zeta potential (charges) and the ease of grafting of E, / E 2 , cellulose and its derivatives (eg cellulose acetate, regenerated cellulose) as well as (co) polyamides being particularly preferred.
  • macromolecular compound preferably chosen from proteins, polysaccharides, synthetic (co) polymers and their mixtures and / or alloys, etc., these compounds being chosen for their porosity, thickness, zeta potential (charges) and the ease of grafting of E, / E 2 , cellulose and its derivatives (eg cellulose acetate, regenerated cellulose)
  • the enzymatic membrane is in the form of a monolayer or multilayer film, preferably substantially planar, once mounted in the device.
  • the enzymatic membrane constitutes all or part of the wall of at least one tube whose lumen forms one of the compartments C, / C ⁇ .
  • pairs of enzymes that can be used in the process and the device according to the invention.
  • these pairs E ⁇ / E 2 are mainly chosen from the pairs of enzymes E j / E 2 allowing the addition / removal of a charged chemical group on a metabolite, preferably among the pairs d enzymes E, / E 2 of phosphorylation / dephosphorylation, and even more preferably among kinases / phosphatases.
  • the method according to the invention can be applied for the purpose of recovering molecules with high added value: chemical, pharmaceutical, cosmetic or other, for the purpose of elimination and isolation of toxic compounds, or else to the purpose of lowering the analytical detection thresholds so as to make analyzes possible.
  • Figure 1 shows a simplified diagram of the first embodiment of the separation and concentration device according to the invention (discontinuous mode ).
  • FIG. 2 is a symbolic representation of the enzymatic membrane separating the two compartments C j and C ⁇ of the device of Figure 1 or 4, said representation corresponding to a first enzymatic pathway of active transfer through the membrane and overconcentration d '' A compound, from compartment II to compartment I
  • Figure 3 is a symbolic representation of the same nature as Figure 2, with the difference that it concerns a second enzymatic pathway for transfer through the membrane and over-concentration of a compound B, from compartment II to compartment I
  • FIG. 4 is a simplified diagram illustrating the second embodiment of the separation and concentration device according to the invention (continuous mode).
  • FIG. 5a shows a simplified view in straight cross section along the line V-V in Figure 4.
  • FIG. 5b is a magnified view of one of the elements of the tubular membrane seen in section in Figure 5a.
  • the device for separating and concentrating at least one compound to be concentrated Pac is designated in FIG. 1 by the general reference 1.
  • This device or reactor 1 is constituted by a tank 2 thermostatically controlled with a double wall, intended for the circulation of a thermoregulating fluid, between inlet 2 and outlet 2 2 .
  • This tank 2 has, for example, a generally substantially hollow cylindrical shape and can be produced from any suitable material, metallic, plastic (polymer e.g. of the polymethacrylate type).
  • This tank contains a liquid medium not referenced in the drawing and is also equipped with stirring means 3 symbolically represented and which are advantageously constituted by a rotor, which can be, for example, a magnetic bar operating with a magnetic stirrer, or still a classic stirring propeller.
  • stirring means 3 symbolically represented and which are advantageously constituted by a rotor, which can be, for example, a magnetic bar operating with a magnetic stirrer, or still a classic stirring propeller.
  • a tubular body 4 also containing liquid medium, partially bathes in the liquid medium contained in the tank 2.
  • This tubular body 4 advantageously has a circular cross section.
  • the submerged lower end of this tubular body 4 is closed by an enzymatic membrane 5 inserted between two annular peripheral seals 6, made - for example - of paraffinic plastic.
  • the membrane 5 is secured to the tubular body 4 via a lip 7 or an annular rim formed at the free immersed end of said tubular body.
  • the fixing means used are for example screws and nuts 8, eg in Teflon.
  • the tubular body 4 is equipped with stirring means 9, of the paddle type agitator.
  • the liquid levels in the tank 2 (1st container) and in the tubular body 4 (2nd container) are adjusted so that they are identical.
  • This membrane 5 also separates said compartment C, from compartment C ⁇ constituted by the tank 2 filled with liquid medium.
  • the membrane 5 is made of natural polymer, modified or not, or of synthetic polymer. In this case, it is a polyamide membrane sold by Pall Europe limited, Portsmouth England under the reference PallNAZ, in the form of nonwoven material, having a thickness of 100 ⁇ m eg
  • the porosity of this membrane is defined by the cut-off threshold, the latter being naturally chosen as a function of the size of the molecules which it is desired to migrate through the membrane in order to over-concentrate them in a compartment. Expressed in maximum molecular weight for the molecules likely to migrate through the pores, this cut-off threshold is advantageously between 500 and 10,000 D, depending on the size of the molecules that one wants to over-concentrate.
  • this membrane can also be made of regenerated cellulose and is in the form of a nonwoven film with a thickness of between 10 and 100 ⁇ m.
  • Each of the faces of the membrane 5 opposite, respectively, of compartment C, and of compartment C ⁇ was subjected to a grafting of enzymes E j E 2 , forming a pair of reversible enzymes in which the enzyme E j is able to catalyze the transformation of A into B and the enzyme E 2 the transformation of B into A.
  • the grafting of the enzyme can be of a covalent nature or even a simple inclusion of the enzyme by absorption within the fibrous polymer matrix. Covalent grafting can be carried out according to conventional techniques. The examples which follow give an illustration of the enzymatic grafting. The symbolic representation of FIG.
  • FIG. 2 shows the membrane 5 supporting in its face opposite compartment C ⁇ the enzyme E 2 and in its facing face of compartment C ,, the enzyme E, of the pair of reversible enzymes E, / E 2 .
  • This membrane has a thickness d and is adjoined by its carrier face of E 2 with a diffusion layer ⁇ of thickness ⁇ 2 , and by its carrier face of E, with another diffusion layer ⁇ of thickness ⁇ ,.
  • component A plays the role of substrate in compartment C Pain and therefore of compound to be concentrated Pac in compartment C, .
  • the substrate and product A and B are assigned an exponent ⁇ or b depending on whether they are in a diffusion layer ⁇ or in the rest of the compartment (b for bulk in English), respectively.
  • a and B are also identified by a first index in Roman numeral corresponding to the compartment in which it is located, followed by a second index t designating time.
  • the goal is to over-concentrate compartment C, in compound B by taking it from compartment Cn and making it pass through the membrane. In this case, it is therefore compound A, which serves as a transmembrane migratory intermediary.
  • the enzyme E is this time in the face of the membrane facing compartment C ⁇ and the enzyme E 2 is included in the face of the membrane facing compartment C ,.
  • E 1 E enzymatic and transmembrane migration is therefore: * °.
  • E t alkaline phosphatase
  • the stirring conditions of the means 3 and 9 are adjusted. This adjustment can be carried out on the basis of the article by BARDELETTI et al., 1985, whose references are as follows: Bardeletti, G; Ma ⁇ sterrena, B. Coulet, PR. (1985) J. Membr. Sci 24, 285-296).
  • the thickness of the diffusion layers ⁇ , and ⁇ 2 is between 50 and 500 ⁇ m, according to the hyrodynamic conditions.
  • the volume ratio between the compartments C 1 and C 11 is chosen (C, playing the role of inlet compartment (or receiver) in which the over-concentration in Pac occurs) , so that this ratio is as low as possible if you want to over-concentrate the Pac in a short time.
  • the pH is between 8 and 10 (buffer)
  • the temperature is between 20 and 30 ° C, preferably of the order of 25 ° C
  • a source of ATP is introduced into the medium in the form of an aqueous saline solution (ATP / MgCl 2 ).
  • the Pac compound is loaded, it is appropriate that at least one of the faces of the membrane, preferably both, are loaded with the same sign.
  • the membrane then also being negatively charged so as to have a valve effect and thus to avoid the parasitic backscattering of A through the membrane.
  • FIGS. 2 and 3 The second embodiment of the device according to the invention is shown in Figure 4, in which it is designated by the general reference 10.
  • This reactor 10 comprises a thermostated tank 11 of the same type as that (2) described in the first embodiment of Figure 1.
  • the references ll j and 11 2 respectively denote the inlet and the outlet of the circulation circuit of a thermoregulating fluid in the jacket of the tank 11.
  • This tank 11 contains the liquid medium initially containing the compound Pac and constituting the liquid compartment C ⁇ .
  • Means 12 of mechanical agitation are provided within this liquid medium forming C ,,.
  • These stirring means 12 are of the same type as those described for the first embodiment shown in the
  • the enzymatic membrane consists of a plurality of tubes 13 with porous walls and grouped together to form a bundle 14, part of which is immersed in the liquid medium of the tank.
  • the lights of the tubes 13 constitute as many compartments C, liquid, involved in the method according to the invention.
  • FIG. 5a shows the bundle 14 of tubular enzymatic membranes 13.
  • This bundle 14 has a curved U-shaped part, the base of which dips into the liquid compartment C ⁇ defined by the tank 11.
  • This tubular bundle 14 is intended to allow the circulation of liquid medium to be over-concentrated in Pac by active transmembrane migration.
  • the bundle 14 is equipped with circulating means 15 constituted, for example, by a pump.
  • Figure 5b is a right cross-sectional view of a tubular enzymatic membrane 13 constituting the bundle 14 and delimiting through its wall, on the one hand, an internal compartment C (tube lumen), and on the other hand, as regards the submerged part of the bundle 14, an external compartment C ⁇ , defined by the tank 11.
  • the wall of the tube 13 comprises on each of these faces internal and external an enzyme E, and E 2 respectively, constituting a pair of reversible enzymes E l IE 2 .
  • the methods of fixing and immobilizing the enzymes are the same as those described above.
  • the constituent materials of these tubular membranes are also of the same nature as those mentioned for membrane 5 of FIG. 1.
  • this will be, for example, regenerated cellulose of porous nature, having a cutoff threshold which can vary from 500 to 10,000 D.
  • the agitating means 12 of the tank 11 as well as the setting in motion of the liquid of C ! in the hollow fibers 13 using the pump 15, allow define diffusion layers ⁇ l and ⁇ 2, shown in Figure 5b.
  • the latter also shows the internal diameter D of the hollow fiber 13, as well as the thickness d of the membrane wall charged with enzymes E j E ⁇
  • the multiple compartments C r constituted by the holes in the hollow fibers 13 serve as the seat for the over-concentration in Pac originating from the compartment C ⁇ .
  • the sum of the volumes of the compartments C ⁇ immersed in C ⁇ is less than the volume V ⁇ of the compartment C ⁇ .
  • the ratio VV ⁇ is as low as possible.
  • the tubular membranes 13 can be electrically charged in positive or in negative, so as to ensure the valve effect and the promoter effect of transmembrane diffusion of the substrates and of the products A and B charged.
  • the liquid medium of over-concentration of the Pac. could be C ⁇ , that is to say the liquid medium contained in the tank 11, the lights C, tubes 13 forming the starting compartment of the Pac.
  • This second embodiment of the device according to the invention is suitable for the second form of continuous implementation of the separation / over-concentration process.
  • the speed of circulation of the liquid medium of the compartments C is adapted to the total surface of the exchange zone in the submerged part, the kinetics of enzymatic transformation E, / E 2 , as well as the rates of transmembrane diffusion of the products A or B loaded or not.
  • the device used is that described above and shown in FIG. 1.
  • E j glycerolkinase - GK - (EC2.7.1.30) coming from the species celhdomonas (52 units.mg -1 , refg. 6142).
  • E 2 alkaline phosphatase (EC3.1.3.1.) Extracted from bovine intestinal mucosa (1200
  • the enzymes E and E 2 defined above are marketed by the company SIGMA.
  • the immobilization of the enzymes on the membrane operates as follows:
  • the membranes are in the form of discs of 5 cm in diameter which are activated using a solution of sulfliric acid in methanol under reflux for
  • the temperature of the liquid medium is thermostatically controlled by the tank at 25 ° C.
  • the diffusion layers ⁇ , and ⁇ 2 are respectively 100 ⁇ m and 150 ⁇ m.
  • Test 1 0.6 mM
  • Test 2: 0.7 mM
  • Translocation of B glycerol from C, to C ⁇ with transformation
  • concentrations A b ⁇ 0 , B b ⁇ 0 , B b , 0 ⁇ A b nt , B b , jt , B are continuously measured b ,, using analyzers with amperometric electrodes.
  • Figures 6, 7 and 8 appended are graphs showing the evolution of the concentrations of G3P 2- and Glycerol in compartments C, and C ,,, for tests 1 to 3 respectively.
  • FIG 6 clearly shows the over-concentration of G3P 2- (A) in C ,, obtained by active transmembrane transport of Glycerol (B), acting as an intermediary E migratory and resulting from the transformation A ' B in C ⁇ .
  • the translocation (test 2) combined with the enzymatic pumping (test 1) makes it possible to further improve the over-concentration in A (G3P 2- ) in C, (test 3).
  • EXAMPLE II Separation / over-concentration of glycerol 3-phosphate 2- and glycerol in C ,, by using the enzymatic pathways 1 and 2, (FIGS. 2 and 3) respectively, with the same methodology as that used in example 1.
  • the temperature of the liquid medium is thermostatically controlled by the tank at 25 ° C. The other operating conditions vary depending on the tests carried out.
  • Tests 4 to 6 Channel 1 Transport of A from C n into C, membrane E,
  • channel 2 differs from that according to channel 1 (tests 4 to 6), in that:
  • the device used is that described above and shown in FIG. 4.
  • Bundle 14 is made up of 88 hollow fibers 13 made of regenerated cellulose
  • the total internal volume of the beam 1 ml.
  • a (total area) 166 cm 2 .
  • Enzymes: E 2 alkaline phosphatase
  • E, glycerol kinase. These enzymes are of the same nature as those of Examples I and II.
  • the grafting of E j on the internal face of the wall of the fibers 13 takes place as follows: The interior of the fibers is hydrolyzed by filling with 0.1 M KOH for 24 hours. The KOH is used to de-esterify. The fibers are then rinsed with distilled water. Then they are filled with 0.25 M sodium periodate, in the dark, for varying periods of time. At the end of the incubation, they are rinsed with distilled water, to remove the excess periodate. The fibers are then filled with 15% (w / v) urea to which is added 0.9% (v / v) sulfliric acid.
  • E is then fixed inside the fibers, the latter being brought to a concentration of 1 mg.ml -1 , in 0.1 M phosphate buffer pH7.5. The incubation lasts about 24 hours, with gentle shaking. The fibers are then rinsed with distilled water and then put in KCl IM for 15 minutes with gentle stirring. They are rinsed again, then put back for 15 minutes in KCl IM and rinsed one last time.
  • Aw 20 cm 2
  • Example 3 The device used is the same as that of Example 3, with the difference that, E 2 is grafted inside the fibers 13 and E ⁇ outside.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

The invention concerns a method for separating and superconcentrating of small molecules in liquid phase, by passing them through a biologically active porous membrane (5). This method consists in the following steps: producing enzymatic pumping of the product to be concentrated (Pac) through the membrane (5), delimiting two basins one for starting liquid CI and for final liquid for CII. A couple of reversing enzymes E1/E2 are provided, E1 being fixed on the face of the membrane (5) opposite CI and E2 on the other face; causing E1 or E2 to transform the Pac into an intermediate migrant (IM) capable of passing through the membrane (5) to be subsequently transformed into Pac by the reversing enzyme CII. Liquids CI/CII are moved to produce non-turbulent diffusion layers adjacent to the two faces of the membrane (5); in the event the IM is electrically charged, a current of a kind opposite to that of this IM is provided for the membrane, whereas in the event the IM is neutral, the membrane (5) is provided with the same electric charge as that of the Pac. Finally the accumulated and superconcentrated Pac is collected in CII. The invention also concerns the separator/concentrator reactor (1) for implementing said method.

Description

PROCEDE DE SEPARATION ET DE CONCENTRATION DE PETITES MOLECULES A L'AIDE DE POMPES ENZYMATIQUES MEMBRANAIRES : REACTEUR SEPARATEUR/CONCENTREUR PROCESS FOR SEPARATION AND CONCENTRATION OF SMALL MOLECULES USING MEMBRANE ENZYMATIC PUMPS: SEPARATOR / CONCENTRATOR REACTOR
DOMAINE TECHNIQUE :TECHNICAL AREA :
Le domaine de la présente invention est celui de la séparation et de la surconcentration de petites molécules en phase liquide, par passage au travers d'une membrane poreuse bioactive. En d'autres termes, il s'agit du transport actif de certains solutés que l'on cherche à isoler et/ou à sur-concentrer.The field of the present invention is that of the separation and over-concentration of small molecules in the liquid phase, by passage through a porous bioactive membrane. In other words, it is the active transport of certain solutes that one seeks to isolate and / or to over-concentrate.
Plus précisément, l'invention se réfère aux techniques de purification/séparation/concentration de molécules - généralement de petite taille - et présente dans des milieux liquides à l'état de traces. De telles molécules très diluées peuvent être intéressantes à purifier ou à isoler soit parce qu'elles présentent une haute valeur ajoutée par exemple dans l'industrie pharmaceutique, soit parce qu'elles constituent une charge polluante indésirable dans ces milieux liquides, soit parce qu'elles sont en dessous du seuil de détection analytique.More specifically, the invention refers to the techniques of purification / separation / concentration of molecules - generally small - and present in liquid media in the trace state. Such highly diluted molecules may be advantageous to purify or to isolate either because they have a high added value, for example in the pharmaceutical industry, or because they constitute an undesirable polluting load in these liquid media, or because they are below the analytical detection threshold.
L'invention concerne ainsi spécifiquement un procédé et un dispositif de séparation et de concentration d'au moins un composé chimique, ci-après dénommé produit à concentrer = Pac, présent dans un milieu liquide sous forme solubilisée.The invention thus relates specifically to a process and a device for separating and concentrating at least one chemical compound, hereinafter referred to as the product to be concentrated = Pac, present in a liquid medium in dissolved form.
ETAT DE LA TECHNIQUE :STATE OF THE ART:
Les techniques de surconcentration connues à ce jour et mises en oeuvre industriellement, répondent difficilement et imparfaitement aux objectifs évoqués ci- dessus.The techniques of over-concentration known to date and implemented industrially, hardly and imperfectly meet the objectives mentioned above.
Ces techniques connues font intervenir des membranes passives, poreuses, au travers desquelles les molécules diffusent sous l'effet d'une surpression. Une telle technologie de filtration forcée, n'est que peu sélective et peu performante sur le plan des ratios de surconcentration surtout pour les petites molécules. Les techniques de surconcentration forcées par surpression sont délicates à mettre en oeuvre, contraignantes pour le matériel dont notamment les membranes et extrêmement consommatrices d'énergie, donc coûteuses.These known techniques involve passive, porous membranes, through which the molecules diffuse under the effect of an overpressure. Such forced filtration technology is not very selective and ineffective in terms of over-concentration ratios, especially for small molecules. The techniques of overconcentration forced by overpressure are difficult to implement, restrictive for the material including in particular the membranes and extremely energy consuming, therefore costly.
On connaît également la dialyse par diffusion passive de soluté au travers de membrane poreuse. La dialyse n'est efficace que pour des molécules présentes en quantité significative d'un côté de la membrane et aptes à traverser cette dernière sous l'effet d'un gradient de concentration. Il est clair que la dialyse ne permet pas de surconcentrer des molécules présentes à l'état de traces dans un liquide de l'autre côté de la membrane. Force est donc de constater la carence, dans l'état de la technique, en moyens de surconcentration de petites molécules (Poids moléculaire < 1000 Daltons) présentes dans des milieux liquides - plus particulièrement en très petites quantités - et dont la surconcentration est exploitable : dans la récupération lorsqu'il s'agit de molécules de haute valeur ajoutée (chimique et/ou pharmaceutiques),Dialysis is also known by passive diffusion of solute through a porous membrane. Dialysis is only effective for molecules present in significant quantities on one side of the membrane and capable of crossing the latter under the effect of a concentration gradient. It is clear that dialysis does not allow molecules that are present in trace amounts to be over-concentrated in a liquid on the other side of the membrane. It is therefore necessary to note the deficiency, in the state of the art, in means of over-concentration of small molecules (Molecular Weight <1000 Daltons) present in liquid media - more particularly in very small quantities - and whose over-concentration is exploitable: in recovery when it comes to molecules with high added value (chemical and / or pharmaceutical),
- dans la dépollution lorsqu'il s'agit de molécules toxiques et/ou indésirables)- in depollution when toxic and / or undesirable molecules are involved)
- et dans la détection desdites molécules présentes à l'état de traces.- And in the detection of said molecules present in trace amounts.
BREVE DESCRIPTION DE L'INVENTIONBRIEF DESCRIPTION OF THE INVENTION
Dans cet état de fait, l'un des objectifs essentiel de la présente invention est de pallier cette carence, en fournissant un procédé de séparation et de concentration d'au moins un Produit à concentrer Pac, présent dans un milieu liquide sous forme solubilisée. Plus précisément, le but visé par ce procédé serait de faire migrer le Produit Pac d'un compartiment de départ du milieu liquide faiblement concentré en Pac, vers un autre compartiment d'arrivée du milieu liquide, dans lequel il s'accumulerait de telle sorte que sa concentration dans ledit compartiment d'arrivée croisse. Un autre objectif essentiel de l'invention est de fournir un procédé de séparation/surconcentration d'un ou plusieurs solutés, qui soit sélectif et qui permette d'obtenir un « surconcentrat » pur ou sensiblement pur.In this state of affairs, one of the essential objectives of the present invention is to remedy this deficiency, by providing a process for the separation and concentration of at least one Pac concentrating product, present in a liquid medium in dissolved form. More specifically, the aim of this process would be to migrate the Pac Product from a starting compartment of the liquid medium weakly concentrated in Pac, to another compartment arriving from the liquid medium, in which it would accumulate in such a way that its concentration in said arrival compartment increases. Another essential objective of the invention is to provide a process of separation / over-concentration of one or more solutes, which is selective and which makes it possible to obtain a pure or substantially pure “over-concentrate”.
Un autre objectif essentiel de la présente invention est de fournir un procédé de séparation/surconcentration d'au moins un soluté Pac, conduisant à des rapports de surconcentration d'un compartiment de départ vers un compartiment d'arrivée, nettement supérieurs à 1.Another essential objective of the present invention is to provide a method of separation / over-concentration of at least one Pac solute, leading to over-concentration ratios from a departure compartment to an arrival compartment, clearly greater than 1.
Un autre objectif essentiel de l'invention est de fournir un procédé de séparation/surconcentration d'un soluté Pac, qui soit simple à mettre en oeuvre et économique.Another essential objective of the invention is to provide a separation / over-concentration process for a Pac solute, which is simple to implement and economical.
Un autre objectif essentiel de la présente invention est de fournir un dispositif de séparation et de concentration d'au moins un Produit à concentrer Pac, présent dans un milieu liquide sous forme solubilisé notamment pour la mise en oeuvre du procédé tel qu'évoqué supra. S'étant fixé ces objectifs, l'inventeur a eu le mérite de mettre en évidence, après de longues et laborieuses recherches et expérimentations, le fait qu'il était envisageable de mettre en oeuvre un système de transport actif d'un soluté Pac, d'un compartiment liquide de départ à un autre compartiment liquide d'arrivée, par pompage enzymatique au travers d'une membrane poreuse. Ce principe mis en lumière par l'inventeur repose sur l'intervention d'un couple d'enzyme réversibles, l'une des enzymes du couple étant fixée sur une face de la membrane poreuse et l'autre enzyme sur la face opposée de ladite membrane. Le produit ou le substrat lié à ce couple d'enzymes est chargé avec un signe soit opposé, soit identique à celui d'au moins l'une des faces de la membrane. Le transfert d'un composé Pac s'effectue en fait au travers de son produit de transformation enzymatique par l'une des enzymes du couple mis en oeuvre. Dans tout le présent exposé, ce produit de transformation sera dénommé « intermédiaire migrateur ». Si l'intermédiaire migrateur est chargé, alors la membrane sera d'un signe opposé de manière à favoriser la diffusion transmembranaire de ce produit chargé. Si l'intermédiaire migrateur n'est pas chargé, alors la membrane est chargée du même signe que le composé Pac que l'on cherche à surconcentrer, de façon à produire ainsi un effet de clapet s'opposant au retour du produit Pac dans le compartiment de départ. C'est ainsi que la présente invention concerne un procédé simultané de séparation et de concentration d'au moins un Produit à Concentrer (Pac), présent dans un milieu liquide sous forme solubilisée, caractérisé en ce qu'il consiste essentiellement et successivement ou non : - à sélectionner au moins un couple d'enzymes réversibles Ej/E2,Another essential objective of the present invention is to provide a device for separating and concentrating at least one Pac concentrating product, present in a liquid medium in dissolved form, in particular for implementing the method as mentioned above. Having set these objectives, the inventor had the merit of highlighting, after long and painstaking research and experiments, the fact that it was possible to implement an active transport system of a Pac solute, from a starting liquid compartment to another incoming liquid compartment, by enzymatic pumping through a porous membrane. This principle highlighted by the inventor is based on the intervention of a pair of reversible enzymes, one of the pair's enzymes being fixed on one side of the porous membrane and the other enzyme on the opposite side of said membrane. The product or the substrate linked to this pair of enzymes is loaded with a sign that is either opposite or identical to that of at least one of the faces of the membrane. The transfer of a Pac compound is carried out in fact through its enzymatic transformation product by one of the enzymes of the couple used. Throughout this presentation, this transformation product will be referred to as a “migratory intermediary”. If the migratory intermediate is charged, then the membrane will be of an opposite sign so as to favor the transmembrane diffusion of this charged product. If the migrating intermediate is not loaded, then the membrane is loaded with the same sign as the Pac compound which one seeks to over-concentrate, so as to produce a valve effect opposing the return of the Pac product in the departure compartment. Thus, the present invention relates to a simultaneous process for the separation and concentration of at least one Concentrated Product (PAC), present in a liquid medium in solubilized form, characterized in that it consists essentially and successively or not : - to select at least one pair of reversible enzymes E j / E 2 ,
Ej étant apte à catalyser la réaction de transformation d'au moins un substrat A en au moins un produit B et E2 la réaction inverse de transformation du (ou des) substrat(s) B en au moins un produit A :E j being able to catalyze the reaction of transformation of at least one substrate A into at least one product B and E 2 the reverse reaction of transformation of the substrate (s) B into at least one product A:
A —B E2 de telle sorteA —B E2 so
* que A ou B corresponde à Pac* whether A or B corresponds to Pac
* et qu'au moins l'un des composés A ou B soit électriquement chargé, - à prévoir au moins une membrane poreuse comprenant E, et E2, respectivement, sur et/ou dans l'une et l'autre de ses faces,* and that at least one of the compounds A or B is electrically charged, - to provide at least one porous membrane comprising E, and E 2 , respectively, on and / or in one and the other of its faces ,
- à immerger la (ou les) membrane(s) poreuse(s) dans le milieu liquide, chaque membrane délimitant au moins en partie au moins un compartiment liquide C, et au moins un compartiment liquide Cπ,- immersing the porous membrane (s) in the liquid medium, each membrane delimiting at least in part at least one liquid compartment C, and at least one liquid compartment C π ,
- à mettre en mouvement au moins l'un des liquides - de préférence les liquides - des compartiments C,/Cπ, en prévoyant au moins une couche de diffusion non-turbulente, attenante à l'une des faces de la ou des membranes, de préférence une couche de diffusion attenante à chaque face de la ou des membranes,- moving at least one of the liquids - preferably the liquids - of the compartments C, / C π , by providing at least one non-turbulent diffusion layer, adjoining one of the faces of the membrane (s) , preferably a diffusion layer adjoining each face of the membrane (s),
- à fixer les conditions opératoires de telle sorte qu'intervienne :- to set the operating conditions so that:
.1. dans le compartiment C, ou Cπ de départ, au moins une transformation enzymatique par E, ou E2, du composé Pac de départ correspondant à A ou B, en métabolite B ou A respectivement selon le cas :.1. in compartment C, or starting C π , at least one enzymatic transformation with E, or E 2 , of the compound Pac start corresponding to A or B, in metabolite B or A respectively as appropriate:
Figure imgf000007_0001
E2 .2. la migration du Pac métabolisé par E, ou E2 intermédiaire migrateur au travers des pores de la membrane pour passer d'un compartiment Cj ou Cπ à l'autre C1I ou C, cette migration intervenant notamment sous l'effet d'un gradient de concentration, avec les conditions selon lesquelles :
Figure imgf000007_0001
E 2 .2. the migration of Pac metabolized by E, or E 2 migrating intermediate through the pores of the membrane to pass from a compartment C j or C π to the other C 1I or C, this migration intervening in particular under the effect of a concentration gradient, with the conditions according to which:
• si l' intermédiaire migrateur est un composé A ou B électriquement chargé, alors chaque membrane est chargée du signe opposé sur au moins l'une de ses faces, de préférence Cette adjacente à la face portant l'enzyme ayant transformé le Pac,If the migrating intermediary is an electrically charged compound A or B, then each membrane is charged with the opposite sign on at least one of its faces, preferably this adjacent to the face carrying the enzyme having transformed the Pac,
• et si l'intermédiaire migrateur est un composé A ou B électriquement neutre alors chaque membrane est chargée électriquement du même signe que l'autre composé A ou B non métabolisé et non migrateur (Pac),• and if the migrating intermediary is an electrically neutral compound A or B then each membrane is electrically charged with the same sign as the other non-metabolized and non-migrating compound A or B (Pac),
.3. puis au moins une transformation enzymatique inverse, par E2 ou Ei, de l'intermédiaire migrateur (B ou A), en Pac de départ, de telle façon que ce dernier s'accumule et se concentre dans le compartiment Cπ ou Cj d'arrivée, - à récupérer le Pac ainsi accumulé et surconcentré. Le principe technique novateur qui gouverne le procédé conforme à l'invention, peut être assimilé à un mécanisme de pompage enzymatique permettant de transférer un soluté Pac dilué dans un compartiment liquide de départ, vers un compartiment liquide d'arrivée, par transport actif au travers d'une membrane poreuse enzymatique. Le soluté Pac s'accumule ainsi et se surconcentre dans le compartiment d'arrivée..3. then at least one reverse enzymatic transformation, by E 2 or Ei, of the migrating intermediate (B or A), into starting Pac, in such a way that the latter accumulates and is concentrated in the compartment C π or C j of arrival, - to recover the Pac thus accumulated and over-concentrated. The innovative technical principle which governs the process according to the invention can be assimilated to an enzymatic pumping mechanism making it possible to transfer a diluted Pac solute in a starting liquid compartment, to a liquid arrival compartment, by active transport through of an enzymatic porous membrane. The Pac solute thus accumulates and over-concentrates in the arrival compartment.
Un tel procédé de pompage enzymatique est particulièrement avantageux puisqu'il permet une surconcentration sélective d'un ou plusieurs solutés Pac, et ce sans consommation exagérée d'énergie, contrairement au système de surconcentration par surpression. En effet, cette pompe enzymatique ne nécessite essentiellement que de l'énergie chimique, qui peut être apportée par exemple par des molécules à liaison riche en énergie, telles que l'adénosine triphosphate (ATP). Un autre avantage du procédé selon l'invention est de conduire à une surconcentration en Pac sous forme relativement pure c'est-à-dire non polluée par l'intermédiaire migrateur.Such an enzymatic pumping process is particularly advantageous since it allows a selective over-concentration of one or more Pac solutes, and this without excessive energy consumption, unlike the system of over-concentration by overpressure. Indeed, this enzymatic pump essentially only requires chemical energy, which can be provided for example by molecules with an energy-rich bond, such as adenosine triphosphate (ATP). Another advantage of the method according to the invention is to lead to an over-concentration of Pac in relatively pure form, that is to say unpolluted by the migratory intermediate.
La mise au point du procédé selon l'invention trouve racine, notamment, dans la compréhension du phénomène de transport actif propre aux membranes biologiques. Cette nouvelle théorie scientifique sur les transports transmembranaires biologiques apporte du sang nouveau à l'état des connaissances scientifiques en la matière. Ce dernier peut se résumer en la théorie basée sur les pores et en la théorie fondée sur la transformation conformationnelle des protéines des membranes biologiques. La démarche nouvelle et innovante selon l'invention a donc consisté, dans un premier temps, à comprendre et expliquer le phénomène biologique et, dans un deuxième temps, à le reproduire (mimétisme) en l'adaptant aux spécifications industrielles de séparation/surconcentration de composés chimiques, en particulier à des fins de récupération de molécules à haute valeur ajoutée : chimique, pharmaceutique, cosmétique ou autres, à des fins d'élimination et d'isolement de composés toxiques, ou bien encore à des fins d'abaissement des seuils de détection analytique de manière à rendre possibles les analyses.The development of the method according to the invention finds its root, in particular, in understanding the phenomenon of active transport specific to biological membranes. This new scientific theory on biological transmembrane transport brings new blood to the state of scientific knowledge on the subject. The latter can be summarized in the theory based on pores and in the theory based on the conformational transformation of proteins of biological membranes. The new and innovative approach according to the invention therefore consisted, firstly, of understanding and explaining the biological phenomenon and, secondly, of reproducing it (mimicry) by adapting it to the industrial specifications of separation / over-concentration of chemical compounds, in particular for recovery of molecules with high added value: chemical, pharmaceutical, cosmetic or other, for the purpose of elimination and isolation of toxic compounds, or even for the purpose of lowering thresholds analytical detection so as to make analyzes possible.
EXPOSE DETAILLE DE L'INVENTIONDETAILED DESCRIPTION OF THE INVENTION
Conformément à l'invention, pour un composé à concentrer Pac donné, il importe tout d'abord de choisir un couple d'enzymes réversibles EXIE2, susceptible de former la pompe enzymatique permettant le transfert du Pac, par l'intermédiaire de son produit de transformation enzymatique par E, ou E2. Le caractère électriquement chargé d'au moins l'un des produit/substrat A et B de E,/E2 est une autre condition essentielle de l'invention, sachant que - le composé A ou B, utile comme intermédiaire migrateur transmembranaire, est neutre ou possède une charge contraire à celle existant sur les faces de la membrane ; et que le composé Pac est neutre ou possède une charge électrique de même signe que celle existant sur au moins l'une des faces de la membrane.In accordance with the invention, for a given compound to concentrate Pac, it is first of all necessary to choose a pair of reversible enzymes E X IE 2 , capable of forming the enzymatic pump allowing the transfer of Pac, via its enzymatic transformation product with E, or E 2 . The electrically charged nature of at least one of the product / substrate A and B of E, / E 2 is another essential condition of the invention, knowing that - Compound A or B, useful as a transmembrane migratory intermediate, is neutral or has a charge opposite to that existing on the faces of the membrane; and that the Pac compound is neutral or has an electrical charge of the same sign as that existing on at least one of the faces of the membrane.
La charge électrique des faces de la membrane poreuse peut être obtenue par exemple, en immobilisant avec Ej et E2 des polyaminoacides dont les pK confèrent à la membrane, pour un pH donné, des charges négatives ou positives. Ainsi, dans le cas où le polyaminoacide est e.g. la polylysine, alors la membrane est chargée positivement à pH 9, tandis qu'avec un polyaminoacide correspondant e.g. à un polyglutamate, la membrane est chargée négativement à pH 9.The electrical charge of the faces of the porous membrane can be obtained for example, by immobilizing with E j and E 2 polyamino acids, the pK of which give the membrane, for a given pH, negative or positive charges. Thus, in the case where the polyamino acid is eg polylysine, then the membrane is positively charged at pH 9, while with a polyamino acid corresponding eg to a polyglutamate, the membrane is negatively charged at pH 9.
Selon une alternative pour charger la membrane, on peut choisir des membranes dont le potentiel zêta au pH optimum est adapté à des conditions données du procédé de l'invention. Cette membrane poreuse doit être agencée de telle sorte qu'elle délimite au moins en partie, une fois immergée dans le milieu liquide, au moins un compartiment C,- de préférence un - et au moins un compartiment Cπ - de préférence un.According to an alternative for loading the membrane, it is possible to choose membranes whose zeta potential at optimum pH is adapted to given conditions of the process of the invention. This porous membrane must be arranged in such a way that it delimits at least in part, once immersed in the liquid medium, at least one compartment C, - preferably one - and at least one compartment C π - preferably one.
Le fait de prévoir une couche de diffusion non turbulente attenante à chaque face de la ou des membranes est une disposition importante du procédé selon l'invention.The fact of providing a non-turbulent diffusion layer adjoining each face of the membrane (s) is an important provision of the method according to the invention.
De préférence, le compartiment Cx ou Cπ de départ du Pac a un volume supérieur à celui du compartiment C„ ou C, d'arrivée. Avantageusement, le ratioPreferably, the compartment C x or C π from the start of the PAC has a volume greater than that of the compartment C „or C, for arrival. Advantageously, the ratio
Volume de C, ou II d'arrivée/V de Cπ ou , de départ doit être le plus faible possible, ce ratio jouant sur la cinétique du transport (mais non sur le rapport final de surconcentration).Volume of C, or II of arrival / V of C π or, of departure must be as low as possible, this ratio playing on the kinetics of transport (but not on the final report of over-concentration).
Pour que les transformations enzymatiques Ej E2 interviennent au voisinage de chacune des faces de la ou des membranes, il est important de prévoir non seulement les couches de diffusion évoquées ci-dessus mais également de mettre en place des conditions opératoires optimales, notamment de pH et de température.In order for the enzymatic transformations E j E 2 to take place in the vicinity of each of the faces of the membrane (s), it is important to provide not only the diffusion layers mentioned above but also to set up optimal operating conditions, in particular to pH and temperature.
On aura compris que le transport actif transmembranaire selon l'invention, passe par l'exploitation d'un premier effet que l'on peut dénommer « effet de clapet » et/ou d'un deuxième effet que l'on peut dénommer effet de promotion de la diffusion de l'intermédiaire migrateur.It will be understood that the active transmembrane transport according to the invention, passes by the exploitation of a first effect which one can call “flapper effect” and / or a second effect which can be called the effect of promoting the dissemination of the migratory intermediary.
L'effet de clapet est obtenu en faisant en sorte que le Pac dont on souhaite limiter la migration au travers de la membrane, soit d'un signe opposé à cette dernière, de manière à être repoussé par celle-ci et ainsi ne pas avoir tendance à la traverser.The valve effect is obtained by ensuring that the Pac, the migration of which it is desired to limit through the membrane, is of a sign opposite to the latter, so as to be repelled by it and thus not having tendency to cross it.
En revanche, dans l'effet promotion de la diffusion, on joue sur le caractère opposé des signes de l'intermédiaire migrateur qui traverse la membrane et de la membrane elle-même, qui a ainsi tendance à attirer l'intermédiaire migrateur.On the other hand, in the promotion of diffusion effect, we play on the opposite character of the signs of the migratory intermediary which crosses the membrane and of the membrane itself, which thus tends to attract the migratory intermediary.
L'invention n'est pas limitée à la mise en oeuvre d'un seul de ces effets. Il est tout à fait possible de prévoir leur cumul.The invention is not limited to the implementation of only one of these effects. It is entirely possible to predict their cumulation.
Les étapes - 1 - de transformation enzymatique dans un sens, - 2 - de migration transmembranaire et - 3 - de transformation enzymatique dans l'autre sens, respectivement, conduisent à une surconcentration du Pac dans le compartiment d'arrivée. Il est alors aisé soit de récupérer le Pac à des fins de valorisation (évaporation du solvant) ou d'élimination, soit de détecter et/ou de doser le Pac qui titre désormais au delà de son seuil de détecton analytique.The steps - 1 - of enzymatic transformation in one direction, - 2 - of transmembrane migration and - 3 - of enzymatic transformation in the other direction, respectively, lead to an over-concentration of Pac in the arrival compartment. It is then easy either to recover the Pac for recovery purposes (evaporation of the solvent) or elimination, or to detect and / or measure the Pac which now titer beyond its analytical detection threshold.
Selon un premier mode de mise en oeuvre du procédé selon l'invention (que l'on peut qualifier de « discontinu»), la membrane enzymatique se présente sous la forme d'un film mono ou multicouche, de préférence sensiblement plan.According to a first embodiment of the method according to the invention (which can be described as "discontinuous"), the enzymatic membrane is in the form of a monolayer or multilayer film, preferably substantially planar.
Ce mode discontinu correspond par exemple au cas de figure dans lequel on a un réacteur formé par un premier conteneur contenant le milieu liquide dans lequel est au moins partiellement immergé un deuxième conteneur. La partie immergée de ce deuxième conteneur étant constituée au moins en partie par la membrane enzymatique poreuse. Ces deux conteneurs définissent les compartiments C, ou „.This discontinuous mode corresponds for example to the case in which there is a reactor formed by a first container containing the liquid medium in which a second container is at least partially immersed. The submerged part of this second container being constituted at least in part by the porous enzymatic membrane. These two containers define compartments C, or „.
La membrane peut former tout ou partie de la paroi du conteneur. De manière préférée, cette membrane constitue une partie sensiblement plane de la paroi de séparation entre les deux compartiments Cj et Cπ.The membrane can form all or part of the wall of the container. Preferably, this membrane constitutes a substantially planar part of the partition wall between the two compartments C j and C π .
Selon un deuxième mode de mise en oeuvre du procédé selon l'invention, (que l'on qualifiera de « continu »), la membrane enzymatique est sous forme tubulaire et plus précisément constitue tout ou partie de la paroi d'un tube, dont la lumière forme l'un des compartiments Cj/Cu.According to a second embodiment of the method according to the invention (which will be called "continuous"), the enzymatic membrane is in the form tubular and more precisely constitutes all or part of the wall of a tube, the lumen of which forms one of the compartments C j / C u .
Avantageusement, la membrane enzymatique peut être faite d'une pluralité de fibres creuses ou membranes tubulaires, de préférence réunis en faiscea(x). Conformément à ce deuxième mode continu, on fait baigner au moins une partie de cette (ou ces) membrane(s) tubulaire(s) dans le milieu liquide formant l'autre compartiment Ci C, et on fait circuler un liquide à enrichir ou à appauvrir en composé Pac, dans cette (ou ces) membrane(s) enzymatique(s) tubulaire(s).Advantageously, the enzymatic membrane can be made of a plurality of hollow fibers or tubular membranes, preferably united in a bundle (x). In accordance with this second continuous mode, at least part of this (or these) tubular membrane (s) is immersed in the liquid medium forming the other compartment Ci C, and a liquid is circulated to be enriched or deplete the Pac compound in this (or these) tubular enzymatic membrane (s).
En pratique, on fait appel dans ce mode continu, à un réacteur formant l'un des compartiment C, ou Cπ contenant le milieu liquide et l'on immerge la ou les membranes tubulaires dans ce réacteur, la circulation du liquide dans la ou les membranes tubulaires constituant l'autre ou les autres compartiments Cπ ou ,, étant assurée par tout moyen approprié tel qu'une pompe.In practice, in this continuous mode, use is made of a reactor forming one of the compartments C, or C π containing the liquid medium and the tubular membrane (s) are immersed in this reactor, the circulation of the liquid in the or the tubular membranes constituting the other or the other compartments C π or ,, being provided by any suitable means such as a pump.
A la lecture de ce qui précède, on perçoit aisément l'importance du milieu liquide des compartiments Ct et C„, et notamment de leurs caractéristiques physicochimiques, pour la conduite du procédé selon l'invention.On reading the above, one can easily perceive the importance of the liquid medium of the compartments C t and C „, and in particular their physicochemical characteristics, for the conduct of the process according to the invention.
Ainsi, selon une autre modalité intéressante du procédé selon l'invention, on ajuste les paramètres pH et température des milieux liquides, de manière à obtenir un optima en cinétique et en rendement pour les transformations enzymatiques par E, et E2.Thus, according to another advantageous modality of the method according to the invention, the pH and temperature parameters of the liquid media are adjusted, so as to obtain an optimum in kinetics and in yield for the enzymatic transformations by E, and E 2 .
En pratique, on élabore donc le milieu liquide de C, et/ou Cn en ayant recours à un solvant - de préférence essentiellement aqueux -, comprenant éventuellement des solutés choisis dans le groupe suivant : o tampons de pH adaptés aux pH optimum de fonctionnement de E, et E2, o molécules à liaisons riches en énergie - avantageusement ATP ou toute molécule susceptible de transférer un groupement phosphate sur un soluté (par exemple : phosphoénol pyruvate, carbamyl phosphate, phosphocréatine...) o et leurs mélanges, les compositions de départ des milieux liquides de Cj et C,j étant, de préférence, sensiblement les mêmes ou non de la concentration en Pac. Outre le réglage du pH et la fourniture de source d'énergie chimique nécessaire aux transformations enzymatiques E, et E2 ; on régule également la température des milieux liquides par apport ou évacuation de calories, e.g. réacteur thermostaté avec double paroi de circulation de fluide régulateur de température. Avantageusement, on fait en sorte que le compartiment C,/Cι, récepteur de l'intermédiaire migrateur au travers de la membrane, comprenne au départ une concentration en cet intermédiaire, inférieure à celle existant dans le compartiment émetteur.In practice, the liquid medium of C and / or Cn is therefore prepared by using a solvent - preferably essentially aqueous - optionally comprising solutes chosen from the following group: o pH buffers adapted to the optimum operating pH of E, and E 2 , o molecules with energy-rich bonds - advantageously ATP or any molecule capable of transferring a phosphate group onto a solute (for example: phosphoenol pyruvate, carbamyl phosphate, phosphocreatine ...) o and their mixtures, the compositions starting from the liquid media of C j and C, j being preferably substantially the same or not of the Pac concentration. In addition to adjusting the pH and supplying the chemical energy source necessary for the enzymatic transformations E, and E 2 ; the temperature of the liquid media is also regulated by adding or removing calories, eg thermostatically controlled reactor with double wall for circulation of temperature-regulating fluid. Advantageously, it is ensured that the compartment C, / Cι, receiver of the migratory intermediate through the membrane, initially comprises a concentration of this intermediate, lower than that existing in the transmitting compartment.
Conformément à l'invention, l'obtention des couches de diffusion s'effectue par mise en mouvement du liquide dans chaque compartiment C,/Cπ, cette mise en mouvement s' opérant par agitation - de préférence à l'aide d 'un rotor - dans le premier mode de mise en oeuvre selon l'invention et/ou par circulation dudit liquide suivant le deuxième mode de mise en oeuvre du procédé selon l'invention.According to the invention, the diffusion layers are obtained by setting in motion the liquid in each compartment C, / C π , this setting in motion being effected by stirring - preferably using a rotor - in the first mode of implementation according to the invention and / or by circulation of said liquid according to the second mode of implementation of the method according to the invention.
Par ces biais, on règle les conditions d'agitation et/ou de circulation de façon à ce que la ou les couches de diffusion non turbulentes, aient une épaisseur identique ou différente de part et d'autre de la membrane et comprise entre 1 et 10 fois l'épaisseur de la membrane.By means of these, the stirring and / or circulation conditions are adjusted so that the non-turbulent diffusion layer or layers have an identical or different thickness on either side of the membrane and between 1 and 10 times the thickness of the membrane.
Pour améliorer la cinétique et les performances de transfert de l'intermédiaire métabolisé migrateur, il est possible de prévoir conformément à l'invention, les effets « clapet » et/ou « de promotion de la diffusion », des moyens auxiliaires d'assistance de la migration transmembranaire de (ou des) intermédiaire(s) migrateur(s), lesdits moyens étant de préférence constitués par un gradient de force ionique et/ou électrique, de part et d'autre de la membrane, et plus préférentiellement encore par des gradients de pH (force protomotrice). Selon une variante du procédé de l'invention, on complète la surconcentration du Pac, par pompage enzymatique dudit Pac au travers de la ou des membranes à partir d'un compartiment C, ou C„ contenant du Pac vers un compartiment Cn ou C, à enrichir en Pac, par mise en oeuvre d'une translocation du Pac, cette dernière consistant à introduire dans le compartiment C] ou Cπ de départ chargé en Pac, de l'intermédiaire migrateur A ou B de transformation enzymatique - 1 - du Pac par Ej ou E2, de telle sorte que cet intermédiaire migrateur ajouté migre cumulativement à celui issu de l'étape - 1 -, dans les mêmes conditions que celles de l'étape - 2 -, pour être enfin soumis à l'étape 3 après avoir traversé la membrane, les étapes - 1 -, - 2 -, et - 3 - en cause étant celles telles que définies supra.In order to improve the kinetics and the transfer performance of the migrating metabolized intermediate, it is possible, in accordance with the invention, to provide for the “flap” and / or “diffusion promotion” effects, auxiliary means of assistance for transmembrane migration of (or of) migratory intermediary (ies), said means preferably being constituted by a gradient of ionic and / or electrical force, on either side of the membrane, and more preferably still by pH gradients (protomotor force). According to a variant of the process of the invention, the overconcentration of the Pac is supplemented by enzymatic pumping of the said Pac through the membrane (s) from a compartment C, or C „containing Pac to a compartment Cn or C, to be enriched with Pac, by implementing a translocation of Pac, the latter consisting in introducing into the starting compartment C ] or C π loaded with Pac, the migrating intermediate A or B of enzymatic transformation - 1 - of the Pac by E j or E 2 , so that this added migratory intermediary migrates cumulatively to that from stage - 1 -, under the same conditions as those of stage - 2 -, to be finally subjected to stage 3 after having crossed the membrane, stages - 1 -, - 2 - , and - 3 - at issue being those as defined above.
Une telle association entre le pompage enzymatique conforme à l'invention (transport actif) et la translocation, permet d'améliorer notablement la surconcentration du Pac.Such an association between the enzymatic pumping in accordance with the invention (active transport) and the translocation makes it possible to notably improve the over-concentration of Pac.
La présente invention a également pour objet un dispositif de séparation et de concentration d'au moins un Produit à Concentrer (Pac), présent dans un milieu liquide sous forme solubilisée, notamment pour la mise en oeuvre du procédé tel que défini supra, caractérisé en ce qu'il comprend essentiellement :The present invention also relates to a device for separating and concentrating at least one Concentrated Product (PAC), present in a liquid medium in solubilized form, in particular for implementing the method as defined above, characterized in what it basically includes:
- au moins une membrane enzymatique poreuse, comportant au moins un couple d'enzymes réversibles ElIE2, E, étant apte à catalyser la réaction de transformation d'au moins un substrat A en au moins un produit B et E2 la réaction inverse de transformation du (ou des) substrat(s) B en au moins un produit- at least one porous enzymatic membrane, comprising at least a pair of reversible enzymes E l IE 2 , E, being able to catalyze the reaction of transformation of at least one substrate A into at least one product B and E 2 the reaction reverse of transformation of the substrate (s) B into at least one product
A :AT :
Figure imgf000013_0001
E2 de telle sorte
Figure imgf000013_0001
E 2 so
* que A ou B corresponde à Pac * et qu'au moins l'un des composés A ou B soit électriquement chargé, Ei et E2 étant respectivement supportées par l'une et l'autre des faces de la membrane,* that A or B corresponds to Pac * and that at least one of the compounds A or B is electrically charged, Ei and E 2 being respectively supported by one and the other of the faces of the membrane,
- au moins un conteneur du milieu liquide dans lequel baigne ou est susceptible de baigner la membrane enzymatique pour délimiter au moins partiellement au moins un compartiment liquide C, et au moins un compartiment liquide Cπ,at least one container of the liquid medium in which the enzyme membrane is bathed or capable of bathing in order to at least partially delimit at least one liquid compartment C, and at least one liquid compartment C π ,
- des moyens de mise en mouvement d'au moins l'un des liquides de préférence des liquides des compartiments Cr, Cπ,means for setting in motion at least one of the liquids, preferably liquids from the compartments C r , C π ,
- éventuellement des moyens de réglage de la température du milieu liquide. Avantageusement, chaque membrane est électriquement chargée, sur au moins l'une de ses faces, de préférence sur celle adjacente à la face portant l'enzyme ayant transformé le Pac, et plus préférentiellement encore sur les deux.- Possibly means for adjusting the temperature of the liquid medium. Advantageously, each membrane is electrically charged, on at least one of its faces, preferably on that adjacent to the face carrying the enzyme which has transformed the Pac, and more preferably still on both.
Conformément à une caractéristique préférée de l'invention, cette membrane enzymatique est une matrice poreuse, dans et/ou sur les deux faces de laquelle sont incluses et immobilisées les enzymes Ei, E2 respectivement, cette matrice étant formée par au moins un composé macromoléculaire, de préférence choisi parmi les protéines, les polysaccharides, les (co)polymères synthétiques et leurs mélanges et/ou alliages, etc, ces composés étant choisis pour leurs porosité, épaisseur, potentiel zêta (charges) et la facilité de greffage de E,/E2, la cellulose et ses dérivés (e.g. acétate de cellulose, cellulose régénérée) de même que les (co)polyamides étant particulièrement préférés.According to a preferred characteristic of the invention, this enzymatic membrane is a porous matrix, in and / or on the two faces of which are included and immobilized the enzymes Ei, E 2 respectively, this matrix being formed by at least one macromolecular compound , preferably chosen from proteins, polysaccharides, synthetic (co) polymers and their mixtures and / or alloys, etc., these compounds being chosen for their porosity, thickness, zeta potential (charges) and the ease of grafting of E, / E 2 , cellulose and its derivatives (eg cellulose acetate, regenerated cellulose) as well as (co) polyamides being particularly preferred.
Selon un premier mode de réalisation du dispositif selon l'invention, la membrane enzymatique se présente sous la forme d'un film mono ou multicouche, de préférence sensiblement plan, une fois montée dans le dispositif.According to a first embodiment of the device according to the invention, the enzymatic membrane is in the form of a monolayer or multilayer film, preferably substantially planar, once mounted in the device.
Selon un deuxième mode de réalisation du dispositif selon l'invention, la membrane enzymatique constitue tout ou partie de la paroi d'au moins un tube dont la lumière forme l'un des compartiments C,/Cπ.According to a second embodiment of the device according to the invention, the enzymatic membrane constitutes all or part of the wall of at least one tube whose lumen forms one of the compartments C, / C π .
Les couples d'enzymes susceptibles d'être mis en oeuvre dans le procédé et le dispositif selon l'invention sont nombreux. Pour fixer les idées on peut indiquer que ces couples Eι/E2 sont principalement choisis parmi les couples d'enzymes Ej/E2 permettant l' addition/enlèvement d'un groupement chimique chargé sur un métabolite, de préférence parmi les couples d'enzymes E,/E2 de phosphorylation/déphosphorylation, et plus préférentiellement encore parmi les kinases/phosphatases.There are many pairs of enzymes that can be used in the process and the device according to the invention. To fix the ideas one can indicate that these pairs Eι / E 2 are mainly chosen from the pairs of enzymes E j / E 2 allowing the addition / removal of a charged chemical group on a metabolite, preferably among the pairs d enzymes E, / E 2 of phosphorylation / dephosphorylation, and even more preferably among kinases / phosphatases.
APPLICATION INDUSTRIELLE :INDUSTRIAL APPLICATION:
Le procédé selon l'invention peut être appliqué à des fins de récupération de molécules à haute valeur ajoutée : chimique, pharmaceutique, cosmétique ou autres, à des fins d'élimination et d'isolement de composés toxiques, ou bien encore à des fins d'abaissement des seuils de détection analytique de manière à rendre possibles les analyses.The method according to the invention can be applied for the purpose of recovering molecules with high added value: chemical, pharmaceutical, cosmetic or other, for the purpose of elimination and isolation of toxic compounds, or else to the purpose of lowering the analytical detection thresholds so as to make analyzes possible.
L'invention sera mieux comprise et ses avantages ou autres variantes de réalisation ressortiront bien de la description qui suit, de deux exemples de réalisation du dispositif qui en fait l'objet. Cette description de dispositif sera complétée par des essais de mise en oeuvre du procédé selon l'invention à l'aide des deux dispositifs exemplifiés auparavant correspondant chacun à un mode de mise en oeuvre particulier du procédé de l'invention.The invention will be better understood and its advantages or other alternative embodiments will become apparent from the description which follows, of two exemplary embodiments of the device which is the subject of it. This description of device will be supplemented by tests of implementation of the method according to the invention using the two previously exemplified devices each corresponding to a particular mode of implementation of the method of the invention.
DESCRIPTION DES FIGURES :DESCRIPTION OF THE FIGURES:
La description des deux modes de réalisation du dispositif selon l'invention sera effectuée en référence aux dessins annexés dans lesquels : la Figure 1 représente un schéma simplifié du premier mode de réalisation du dispositif de séparation et de concentration conforme à l'invention (mode discontinu).The description of the two embodiments of the device according to the invention will be made with reference to the accompanying drawings in which: Figure 1 shows a simplified diagram of the first embodiment of the separation and concentration device according to the invention (discontinuous mode ).
- La Figure 2 est une représentation symbolique de la membrane enzymatique séparant les deux compartiments Cj et Cπ du dispositif de la Figure 1 ou 4, ladite représentation correspondant à une première voie enzymatique de transfert actif au travers de la membrane et de surconcentration d'un composé A, du compartiment II vers le compartiment I- Figure 2 is a symbolic representation of the enzymatic membrane separating the two compartments C j and C π of the device of Figure 1 or 4, said representation corresponding to a first enzymatic pathway of active transfer through the membrane and overconcentration d '' A compound, from compartment II to compartment I
Λ E . Membrane _, Eι . A — * B > B > A Λ E. Membrane _, E ι. A - * B>B> A
- La Figure 3 est une représentation symbolique de même nature que la Figure 2, à la différence près qu'elle concerne une deuxième voie enzymatique de transfert au travers de la membrane et de surconcentration d'un composé B, du compartiment II vers le compartiment I- Figure 3 is a symbolic representation of the same nature as Figure 2, with the difference that it concerns a second enzymatic pathway for transfer through the membrane and over-concentration of a compound B, from compartment II to compartment I
_, E. v Membrane, . E2 . B — ^A > A > B - La Figure 4 est un schéma simplifié illustrant le deuxième mode de réalisation du dispositif de séparation et de concentration conforme à l'invention (mode continu)._, E. v Membrane,. E 2. B - ^ A>A> B - Figure 4 is a simplified diagram illustrating the second embodiment of the separation and concentration device according to the invention (continuous mode).
- La Figure 5a met une vue simplifiée en coupe transversale droite selon la ligne V-V de la Figure 4.- Figure 5a shows a simplified view in straight cross section along the line V-V in Figure 4.
- La Figure 5b est une vue grosssie d'un des éléments de la membrane tubulaire vue en coupe sur la Figure 5a.- Figure 5b is a magnified view of one of the elements of the tubular membrane seen in section in Figure 5a.
Le dispositif de séparation et de concentration d'au moins un composé à concentrer Pac, selon le premier mode de réalisation de l'invention, est désigné sur la Figure 1 par la référence générale 1. Ce dispositif ou réacteur 1 est constitué par une cuve 2 thermostatée présentant une double paroi, prévue pour la circulation d'un fluide thermorégulateur, entre l'entrée 2 et la sortie 22.The device for separating and concentrating at least one compound to be concentrated Pac, according to the first embodiment of the invention, is designated in FIG. 1 by the general reference 1. This device or reactor 1 is constituted by a tank 2 thermostatically controlled with a double wall, intended for the circulation of a thermoregulating fluid, between inlet 2 and outlet 2 2 .
Cette cuve 2 a, par exemple, une forme générale sensiblement cylindrique creuse et peut être réalisée à partir de tout matériau approprié, métallique, plastique (polymère e.g. du type polyméthacrylate).This tank 2 has, for example, a generally substantially hollow cylindrical shape and can be produced from any suitable material, metallic, plastic (polymer e.g. of the polymethacrylate type).
Cette cuve contient un milieu liquide non référencé sur le dessin et est équipée par ailleurs de moyens d'agitation 3 représentés symboliquement et qui sont avantageusement constitués par un rotor, qui peut être, par exemple, un barreau magnétique fonctionnant avec un agitateur magnétique, ou bien encore une hélice d'agitation classique.This tank contains a liquid medium not referenced in the drawing and is also equipped with stirring means 3 symbolically represented and which are advantageously constituted by a rotor, which can be, for example, a magnetic bar operating with a magnetic stirrer, or still a classic stirring propeller.
Un corps tubulaire 4 contenant également du milieu liquide, baigne partiellement dans le milieu liquide contenu dans la cuve 2. Ce corps tubulaire 4 présente avantageusement une section transversale droite circulaire. L'extrémité inférieure immergée de ce corps tubulaire 4 est obturée par une membrane enzymatique 5 insérée entre deux joints 6 périphériques annulaires, constitués - par exemple - de matière plastique paraffinique. La membrane 5 est solidarisée avec le corps tubulaire 4 par l'intermédiaire d'une lèvre 7 ou d'un rebord annulaire ménagé à l'extrémité libre immergée dudit corps tubulaire. Les moyens de fixation utilisés sont par exemple des vis et écrous 8, e.g. en téflon. Le corps tubulaire 4 est équipé de moyens d'agitation 9, du type agitateur à pale. Les niveaux de liquide dans la cuve 2 (1er conteneur) et dans le corps tubulaire 4 (2ème conteneur) sont ajustés de telle sorte qu'ils soient identiques.A tubular body 4 also containing liquid medium, partially bathes in the liquid medium contained in the tank 2. This tubular body 4 advantageously has a circular cross section. The submerged lower end of this tubular body 4 is closed by an enzymatic membrane 5 inserted between two annular peripheral seals 6, made - for example - of paraffinic plastic. The membrane 5 is secured to the tubular body 4 via a lip 7 or an annular rim formed at the free immersed end of said tubular body. The fixing means used are for example screws and nuts 8, eg in Teflon. The tubular body 4 is equipped with stirring means 9, of the paddle type agitator. The liquid levels in the tank 2 (1st container) and in the tubular body 4 (2nd container) are adjusted so that they are identical.
La membrane enzymatique 5 d'extrémité, délimite avec la paroi du tube 4 le compartiment référencé par C, sur la Figure 1. Cette membrane 5 sépare également ledit compartiment C, du compartiment Cπ constitué par la cuve 2 remplie de milieu liquide.The end enzymatic membrane 5, with the wall of the tube 4, delimits the compartment referenced by C, in Figure 1. This membrane 5 also separates said compartment C, from compartment C π constituted by the tank 2 filled with liquid medium.
Dans cet exemple, le volume interne V, du compartiment C, = 4 cm3, tandis que le volume V„ du compartiment Cπ = 300 cm3. Conformément à l'invention, la membrane 5 est réalisée en polymère naturel modifié ou non ou en polymère de synthèse. En l'occurence, il s'agit ici d'une membrane en polyamide commercialisée par Pall Europe limited, Portsmouth England sous la référence PallNAZ se présentant sous la forme de matériau non tissé, ayant une épaisseur de 100 μm e.g. La porosité de cette membrane est définie par le seuil de coupure, ce dernier étant naturellement choisi en fonction de la taille des molécules que l'on souhaite faire migrer au travers de la membrane pour les surconcentrer dans un compartiment. Exprimé en poids moléculaire maximum pour les molécules susceptibles de migrer au travers des pores, ce seuil de coupure est avantageusement compris entre 500 et 10 000 D, selon la taille des molécules que l'on veut surconcentrer.In this example, the internal volume V, of compartment C, = 4 cm 3 , while the volume V „of compartment C π = 300 cm 3 . According to the invention, the membrane 5 is made of natural polymer, modified or not, or of synthetic polymer. In this case, it is a polyamide membrane sold by Pall Europe limited, Portsmouth England under the reference PallNAZ, in the form of nonwoven material, having a thickness of 100 μm eg The porosity of this membrane is defined by the cut-off threshold, the latter being naturally chosen as a function of the size of the molecules which it is desired to migrate through the membrane in order to over-concentrate them in a compartment. Expressed in maximum molecular weight for the molecules likely to migrate through the pores, this cut-off threshold is advantageously between 500 and 10,000 D, depending on the size of the molecules that one wants to over-concentrate.
Selon une variante, cette membrane peut également être constituée de cellulose régénérée et se présente sous la forme d'un film non tissé d'épaisseur comprise entre 10 et 100 μm.According to a variant, this membrane can also be made of regenerated cellulose and is in the form of a nonwoven film with a thickness of between 10 and 100 μm.
Chacune des faces de la membrane 5 en regard, respectivement, du compartiment C, et du compartiment Cπ, a été soumise à un greffage d'enzymes Ej E2, formant un couple d'enzymes réversibles dans lequel l'enzyme Ej est apte à catalyser la transformation de A en B et l'enzyme E2 la transformation de B en A. Le greffage de l'enzyme peut être de nature covalente ou bien encore une simple inclusion de l'enzyme par absorption au sein de la matrice polymère fibreuse. Le greffage covalent peut être réalisé selon les techniques classiques. Les exemples qui suivent donne une illustration du greffage enzymatique. La représentation symbolique de la Figure 2 montre la membrane 5 supportant dans sa face en regard du compartiment Cπ l'enzyme E2 et dans sa face en regard du compartiment C,, l'enzyme E, du couple d'enzymes réversibles E,/E2. Cette membrane présente une épaisseur d et est attenante par sa face porteuse de E2 avec une couche de diffusion δ d'épaisseur δ2, et par sa face porteuse de E, avec une autre couche de diffusion δ d'épaisseur δ,. Dans la première voie de transformation enzymatique et de migration transmembranaire A — B — » B → A illustrée par la Figure 2, le composant A joue le rôle de substrat dans le compartiment C„ et donc de composé à concentrer Pac dans le compartiment C,. Dans cette Figure 2, les substrat et produit A et B sont affectés d'un exposant δ ou b selon qu'ils se trouvent dans une couche de diffusion δ ou dans le reste du compartiment (b pour bulk en anglais), respectivement. A et B sont également identifiés par un premier indice en chiffre romain correspondant au compartiment dans lequel il se trouve, suivi d'un deuxième indice t désignant le temps. Dans cette première voie au temps t = 0 on a : Ab I1; t ≠ 0 ; Ab , t = Bb 1 t =Each of the faces of the membrane 5 opposite, respectively, of compartment C, and of compartment C π , was subjected to a grafting of enzymes E j E 2 , forming a pair of reversible enzymes in which the enzyme E j is able to catalyze the transformation of A into B and the enzyme E 2 the transformation of B into A. The grafting of the enzyme can be of a covalent nature or even a simple inclusion of the enzyme by absorption within the fibrous polymer matrix. Covalent grafting can be carried out according to conventional techniques. The examples which follow give an illustration of the enzymatic grafting. The symbolic representation of FIG. 2 shows the membrane 5 supporting in its face opposite compartment C π the enzyme E 2 and in its facing face of compartment C ,, the enzyme E, of the pair of reversible enzymes E, / E 2 . This membrane has a thickness d and is adjoined by its carrier face of E 2 with a diffusion layer δ of thickness δ 2 , and by its carrier face of E, with another diffusion layer δ of thickness δ,. In the first pathway of enzymatic transformation and transmembrane migration A - B - »B → A illustrated by FIG. 2, component A plays the role of substrate in compartment C„ and therefore of compound to be concentrated Pac in compartment C, . In this Figure 2, the substrate and product A and B are assigned an exponent δ or b depending on whether they are in a diffusion layer δ or in the rest of the compartment (b for bulk in English), respectively. A and B are also identified by a first index in Roman numeral corresponding to the compartment in which it is located, followed by a second index t designating time. In this first way at time t = 0 we have: A b I1; t ≠ 0; A b , t = B b 1 t =
Dans cette première voie, c'est donc le composé B qui sert d'intermédiaire migrateur transmembranaireIn this first route, it is therefore compound B which serves as a transmembrane migratory intermediary
S'agissant de la deuxième voie représentée à la Figure 3, le but visé est de surconcentrer le compartiment C, en composé B en le prélevant dans le compartiment Cn et en lui faisant traverser la membrane. Dans ce cas, c'est donc le composé A, qui sert d'intermédiaire migrateur transmembranaire. L'enzyme E, est cette fois dans la face de la membrane en regard du compartiment Cπ et l'enzyme E2 est incluse dans la face de la membrane en regard du compartiment C,. La voie de transformationRegarding the second path shown in Figure 3, the goal is to over-concentrate compartment C, in compound B by taking it from compartment Cn and making it pass through the membrane. In this case, it is therefore compound A, which serves as a transmembrane migratory intermediary. The enzyme E, is this time in the face of the membrane facing compartment C π and the enzyme E 2 is included in the face of the membrane facing compartment C ,. The path of transformation
E1 E enzymatique et de migration transmembranaire est donc : *°. E 1 E enzymatic and transmembrane migration is therefore: * °.
La mise en oeuvre du procédé selon l'invention à l'aide du dispositif ci- dessus exemplifié et représenté à la Figure 1, s'opère en sélectionnant le couple d'enzymes réversibles, par exemple Et = phosphatase-alcaline et E2 = glycérol-kinase avec A = glycérol-3 -phosphate2- et B = glycérol. Après immobilisation de ces enzymes sur les faces de la membrane 5, on règle les conditions d'agitation des moyens 3 et 9. Ce réglage peut être effectué en s'inspirant de l'article de BARDELETTI et al., 1985, dont les références sont les suivantes : Bardeletti, G ; Maïsterrena, B. Coulet, PR. (1985) J. Membr. Sci 24, 285-296). Selon une caractéristique préférée de l'invention, l'épaisseur des couches de diffusion δ, et δ2 est comprise entre 50 et 500 μm, selon les conditions hyrodynamiques.The implementation of the method according to the invention using the device above exemplified and shown in Figure 1, operates by selecting the pair of reversible enzymes, for example E t = alkaline phosphatase and E 2 = glycerol kinase with A = glycerol-3-phosphate 2- and B = glycerol. After immobilization of these enzymes on the faces of the membrane 5, the stirring conditions of the means 3 and 9 are adjusted. This adjustment can be carried out on the basis of the article by BARDELETTI et al., 1985, whose references are as follows: Bardeletti, G; Maïsterrena, B. Coulet, PR. (1985) J. Membr. Sci 24, 285-296). According to a preferred characteristic of the invention, the thickness of the diffusion layers δ, and δ 2 is between 50 and 500 μm, according to the hyrodynamic conditions.
Selon une autre disposition du procédé de l'invention, on choisit le rapport de volume entre les compartiments C, et C11, (C, jouant le rôle de compartiment d'arrivée (ou récepteur) dans lequel se produit la surconcentration en Pac), de telle sorte que ce rapport soit le plus faible possible si l'on veut surconcentrer le Pac en un temps court.According to another arrangement of the process of the invention, the volume ratio between the compartments C 1 and C 11 is chosen (C, playing the role of inlet compartment (or receiver) in which the over-concentration in Pac occurs) , so that this ratio is as low as possible if you want to over-concentrate the Pac in a short time.
De préférence, la composition du milieu liquide dans les compartiments C, et Cπ au temps t = 0, est sensiblement la même, y compris en ce qui concerne le composé A ou B à surconcentrer (Pac).Preferably, the composition of the liquid medium in compartments C, and C π at time t = 0, is substantially the same, including as regards compound A or B to be over-concentrated (Pac).
On prévoit également les conditions de pH, de température et de source d'énergie chimique, nécessaires aux enzymes E, E2 pour effectuer des transformations enzymatiques. Ainsi, dans le cas du couple d'enzymes phosphatase alcaline/glycérol- kinase, le pH est compris entre 8 et 10 (tampon), la température est comprise entre 20 et 30° C, de préférence de l'ordre de 25° C et l'on introduit dans le milieu une source d'ATP sous forme de solution saline aqueuse (ATP/MgCl2).It also provides the conditions of pH, temperature and chemical energy source, necessary for enzymes E, E 2 to carry out enzymatic transformations. Thus, in the case of the pair of alkaline phosphatase / glycerol kinase enzymes, the pH is between 8 and 10 (buffer), the temperature is between 20 and 30 ° C, preferably of the order of 25 ° C and a source of ATP is introduced into the medium in the form of an aqueous saline solution (ATP / MgCl 2 ).
Dès lors que l'on a plongé la membrane dans le milieu liquide en fixant par ailleurs les autres paramètres énoncés ci-dessus, le pompage enzymatique suivant l'invention intervient et l'on récupère in fine dans le compartiment C,, soit du composé A = glycérol-3 -phosphate2" soit du composé B = glycérol.As soon as the membrane has been immersed in the liquid medium, by fixing the other parameters set out above, the enzymatic pumping according to the invention takes place and in the end, recovery is made in compartment C ,, of the compound A = 2 "glycerol-3-phosphate or of compound B = glycerol.
Dans le cas où le composé Pac est chargé, il convient qu'au moins une des faces de la membrane, de préférence les deux soient chargées du même signe. Il en est ainsi pour Pac = A = glycérol-3 -phosphate2-, la membrane étant alors elle- aussi chargée négativement de manière à avoir un effet clapet et à éviter ainsi la rétrodiffusion parasite de A au travers de la membrane. Dans le cas où l'intermédiaire migrateur est chargé, alors on prévoit sur au moins l'une des faces de la membrane, de préférence les deux, une charge opposée de manière à favoriser la diffusion transmembranaire de cette intermédiaire migrateur. Il est ainsi pour Pac = B = glycérol et A = glycérol-3 -phosphate2-. Conformément à l'invention il n'est pas à exclure que les deux cas de figure visés ci-dessus se cumulent, c'est-à-dire que A et B soient de signes opposés et que celui constituant l'intermédiaire migrateur soit de signe opposé à la membrane, tandis que le composé correspondant à Pac est de même signe que la membrane.In the case where the Pac compound is loaded, it is appropriate that at least one of the faces of the membrane, preferably both, are loaded with the same sign. This is the case for Pac = A = glycerol-3 -phosphate 2- , the membrane then also being negatively charged so as to have a valve effect and thus to avoid the parasitic backscattering of A through the membrane. In the case where the migratory intermediate is loaded, then an opposite charge is provided on at least one of the faces of the membrane, preferably so as to promote the transmembrane diffusion of this migratory intermediate. It is thus for Pac = B = glycerol and A = glycerol-3-phosphate 2- . In accordance with the invention, it cannot be excluded that the two scenarios referred to above are cumulative, that is to say that A and B are of opposite signs and that that constituting the migratory intermediary is of sign opposite to the membrane, while the compound corresponding to Pac has the same sign as the membrane.
Comme déjà signalé ci-dessus, suivant une variante avantageuse du procédé selon l'invention, on peut associer ou combiner le pompage enzymatique d'un composé Pac A ou B en prévoyant une translocation. Cette manipulation consiste à incorporer de l'intermédiaire migrateur dans le compartiment C, ou Cn de départ du pompage. Dans la première voie Figure 2, on prévoira donc une concentration initiale non nulle en composé B dans le compartiment Cπ et dans la deuxième voie Figure 3, la concentration initiale en composé A dans le compartiment C,, sera de la même façon supérieure à 0.As already indicated above, according to an advantageous variant of the method according to the invention, it is possible to associate or combine the enzymatic pumping of a Pac A or B compound by providing for a translocation. This manipulation consists in incorporating the migrating intermediate in compartment C, or C n of the pumping start. In the first path Figure 2, we will therefore provide an initial non-zero concentration of compound B in compartment C π and in the second path Figure 3, the initial concentration of compound A in compartment C ,, will likewise be greater than 0.
On remarquera que dans les deux voies enzymatiques 1 et 2 selon les Fig. 2 et 3, le Pac traverse également la membrane par diffusion directe dans une mesure largement moindre (flèches en pointillés sur Fig.2 et 3). Le deuxième mode de réalisation du dispositif selon l'invention est représenté sur la Figure 4, sur laquelle il est désigné par la référence générale 10. Ce dispositif 10 de séparation et de concentration d'au moins un composé à concentrer Pac, présent dans un milieu liquide sous forme solubilisé, peut être assimilé à un réacteur séparateur/concentreur, apte à fonctionner selon un mode continu. Ce réacteur 10 comprend une cuve 11 thermostatée du même type que celle (2) décrite dans le premier mode de réalisation de la Figure 1. Les références llj et 112 désignent respectivement l'entrée et la sortie du circuit de circulation d'un fluide thermorégulateur dans la double enveloppe de la cuve 11.It will be noted that in the two enzymatic pathways 1 and 2 according to FIGS. 2 and 3, the Pac also crosses the membrane by direct diffusion to a much lesser extent (dotted arrows in Fig. 2 and 3). The second embodiment of the device according to the invention is shown in Figure 4, in which it is designated by the general reference 10. This device 10 for separation and concentration of at least one compound to be concentrated Pac, present in a liquid medium in solubilized form, can be assimilated to a separator / concentrator reactor, capable of operating in a continuous mode. This reactor 10 comprises a thermostated tank 11 of the same type as that (2) described in the first embodiment of Figure 1. The references ll j and 11 2 respectively denote the inlet and the outlet of the circulation circuit of a thermoregulating fluid in the jacket of the tank 11.
Cette cuve 11 contient le milieu liquide contenant initialement le composé Pac et constituant le compartiment liquide Cπ. Des moyens 12 d'agitation mécanique sont prévus au sein de ce milieu liquide formant C,,. Ces moyens d'agitation 12 sont du même type que ceux décrits pour le premier mode de réalisation représenté à laThis tank 11 contains the liquid medium initially containing the compound Pac and constituting the liquid compartment C π . Means 12 of mechanical agitation are provided within this liquid medium forming C ,,. These stirring means 12 are of the same type as those described for the first embodiment shown in the
Figure 1 et désignés par la référence 9 dans cette figure.Figure 1 and designated by reference 9 in this figure.
Dans ce deuxième mode de réalisation, la membrane enzymatique est constituée par une pluralité de tube 13 à paroi poreuse et regroupés entre eux pour former un faisceau 14, dont une partie est immergée dans le milieu liquide de la cuveIn this second embodiment, the enzymatic membrane consists of a plurality of tubes 13 with porous walls and grouped together to form a bundle 14, part of which is immersed in the liquid medium of the tank.
11 (Cπ).11 (Cπ).
En fait, les lumières des tubes 13 constitue autant de compartiments C, liquides, intervenant dans le procédé selon l'invention.In fact, the lights of the tubes 13 constitute as many compartments C, liquid, involved in the method according to the invention.
Les flèches indiquées sur la Figure 4 dans le faisceau 13 donne le sens de circulation du flux des compartiments Cτ.The arrows indicated in Figure 4 in the beam 13 gives the direction of flow of the flow of the compartments C τ .
La coupe de la Figure 5a montre le faisceau 14 de membranes enzymatiques tubulaires 13.The section in FIG. 5a shows the bundle 14 of tubular enzymatic membranes 13.
Ce faisceau 14 présente une partie recourbée en forme de U, dont la base plonge dans le compartiment Cπ liquide défini par la cuve 11. Ce faisceau tubulaire 14 est destiné à permettre la circulation de milieu liquide à surconcentrer en Pac par migration active transmembranaire. A cette fin, le faisceau 14 est équipé de moyens de mise en circulation 15 constitués, par exemple, par une pompe.This bundle 14 has a curved U-shaped part, the base of which dips into the liquid compartment C π defined by the tank 11. This tubular bundle 14 is intended to allow the circulation of liquid medium to be over-concentrated in Pac by active transmembrane migration. To this end, the bundle 14 is equipped with circulating means 15 constituted, for example, by a pump.
La Figure 5b est une vue en coupe transversale droite d'une membrane enzymatique tubulaire 13 constituant le faisceau 14 et délimitant par l'intermédiaire de sa paroi, d'une part, un compartiment C, interne (lumière du tube), et d'autre part, pour ce qui concerne la partie immergée du faisceau 14, un compartiment Cπ extérieur, défini par la cuve 11. A l'instar de la membrane 5 de la Figure 1, la paroi du tube 13 comprend sur chacune de ces faces interne et externe une enzyme E, et E2 respectivement, constituant un couple d'enzymes réversibles ElIE2. Les méthodes de fixation et d'immobilisation des enzymes sont les mêmes que celles décrites supra. En outre, les matériaux constitutifs de ces membranes tubulaires sont eux aussi de même nature que ceux évoqués pour la membrane 5 de la Figure 1. En pratique, il s'agira par exemple de cellulose régénérée de nature poreuse, présentant un seuil de coupure pouvant varier de 500 à 10 000 D. Les moyens d'agitation 12 de la cuve 11 ainsi que la mise en mouvement du liquide de C! dans les fibres creuses 13 à l'aide de la pompe 15, permettent de définir des couches de diffusion δl et δ2, montrés sur la Figure 5b. Cette dernière fait également apparaître le diamètre interne D de la fibre creuse 13, de même que l'épaisseur d de la paroi membranaire chargée d'enzymes Ej E^Figure 5b is a right cross-sectional view of a tubular enzymatic membrane 13 constituting the bundle 14 and delimiting through its wall, on the one hand, an internal compartment C (tube lumen), and on the other hand, as regards the submerged part of the bundle 14, an external compartment C π , defined by the tank 11. Like the membrane 5 of FIG. 1, the wall of the tube 13 comprises on each of these faces internal and external an enzyme E, and E 2 respectively, constituting a pair of reversible enzymes E l IE 2 . The methods of fixing and immobilizing the enzymes are the same as those described above. In addition, the constituent materials of these tubular membranes are also of the same nature as those mentioned for membrane 5 of FIG. 1. In practice, this will be, for example, regenerated cellulose of porous nature, having a cutoff threshold which can vary from 500 to 10,000 D. The agitating means 12 of the tank 11 as well as the setting in motion of the liquid of C ! in the hollow fibers 13 using the pump 15, allow define diffusion layers δl and δ2, shown in Figure 5b. The latter also shows the internal diameter D of the hollow fiber 13, as well as the thickness d of the membrane wall charged with enzymes E j E ^
De préférence, les multiples compartiments Cr constitués par les lumières des fibres creuses 13 servent de siège à la surconcentration en Pac provenant du compartiment Cπ.Preferably, the multiple compartments C r constituted by the holes in the hollow fibers 13 serve as the seat for the over-concentration in Pac originating from the compartment C π .
La somme des volumes des compartiments Cτ immergés dans Cπ est inférieure au volume Vπ du compartiment Cπ. Le rapport V Vπ est le plus faible possible. Les membranes tubulaires 13 peuvent être électriquement chargées en positif ou en négatif, de manière à assurer l'effet clapet et l'effet promoteur de diffusion transmembranaire des substrats et des produits A et B chargés.The sum of the volumes of the compartments C τ immersed in C π is less than the volume V π of the compartment C π . The ratio VV π is as low as possible. The tubular membranes 13 can be electrically charged in positive or in negative, so as to ensure the valve effect and the promoter effect of transmembrane diffusion of the substrates and of the products A and B charged.
Selon une variante, le milieu liquide de surconcentration du Pac. pourrait être Cπ, c'est-à-dire le milieu liquide contenu dans la cuve 11, les lumières C, des tubes 13 formant le compartiment de départ du Pac.According to a variant, the liquid medium of over-concentration of the Pac. could be C π , that is to say the liquid medium contained in the tank 11, the lights C, tubes 13 forming the starting compartment of the Pac.
Ce deuxième mode de réalisation du dispositif selon l'invention est adapté à la deuxième forme de mise en oeuvre continu du procédé de séparation/ surconcentration. On retrouve la méthodologie employée pour le premier mode discontinu de mise en oeuvre, à la différence près que le milieu liquide des compartiments C, circule dans les fibres creuses 13 enzymatiques, le transport actif transmembranaire de Pac s'opérant naturellement au niveau de la partie immergée du faisceau 14 dans le compartiment Cπ liquide de la cuve 11.This second embodiment of the device according to the invention is suitable for the second form of continuous implementation of the separation / over-concentration process. We find the methodology used for the first discontinuous mode of implementation, with the difference that the liquid medium of the compartments C, circulates in the hollow enzymatic fibers 13, the active transmembrane transport of Pac occurring naturally at the level of the part immersed in the beam 14 in the liquid compartment C π of the tank 11.
La vitesse de circulation du milieu liquide des compartiments C, est adaptée à la surface totale de la zone d'échange dans la partie immergée, des cinétiques de transformation enzymatique E,/E2, ainsi que des vitesses de diffusion transmembranaire des produits A ou B chargés ou non.The speed of circulation of the liquid medium of the compartments C, is adapted to the total surface of the exchange zone in the submerged part, the kinetics of enzymatic transformation E, / E 2 , as well as the rates of transmembrane diffusion of the products A or B loaded or not.
Les exemples qui suivent illustrent le dispositif et le procédé selon l'invention dans leur deux modes préférés mais non exclusif de mise en oeuvre. Ces exemples permettront de mieux comprendre l'invention et d'en saisir tous ses avantages et variantes de réalisation. EXEMPLESThe examples which follow illustrate the device and the method according to the invention in their two preferred but not exclusive modes of implementation. These examples will make it possible to better understand the invention and to grasp all of its advantages and variant embodiments. EXAMPLES
EXEMPLE I : Séparation/surconcentration de glycérolSP2- dans un compartiment C„ par pompage enzymatique à partir d'un compartiment cu, selon le 1er mode de mise en oeuvre du procède de l'invention et a l'aide du dispositif de l'invention dans sa 1ère forme de réalisation - 1. 1. MatérielEXAMPLE I: Separation / over-concentration of glycerolSP 2 - in a compartment C „by enzymatic pumping from a compartment c u , according to the 1st embodiment of the process of the invention and using the device of the invention in its 1st embodiment - 1. 1. Material
Le dispositif mis en oeuvre est celui décrit supra et représenté sur la Fig. 1.The device used is that described above and shown in FIG. 1.
Les membranes mise en oeuvre sont des membranes du type Pall NAZ commercialisées par la société PALL EUROP LIMITED. Ce sont des membranes en polyamide d'épaisseur = à 100 μm de surface active de transfert (Aw) de 12 % et référencées sous le numéro 09025.The membranes used are membranes of the Pall NAZ type sold by the company PALL EUROP LIMITED. These are polyamide membranes with a thickness = 100 μm of active transfer area (Aw) of 12% and referenced under the number 09025.
L'enzyme Ej = glycérolkinase - GK - (EC2.7.1.30) provenant de l'espèce celhdomonas (52 unités.mg-1, refg. 6142). E2 = phosphatase alcaline (EC3.1.3.1.) extraite de muqueuse intestinale bovine (1200The enzyme E j = glycerolkinase - GK - (EC2.7.1.30) coming from the species celhdomonas (52 units.mg -1 , refg. 6142). E 2 = alkaline phosphatase (EC3.1.3.1.) Extracted from bovine intestinal mucosa (1200
Unités.mg-1, réf. P 6672).Units.mg -1 , ref. P 6672).
Les enzymes E, et E2 définies ci-dessus sont commercialisées par la société SIGMA.The enzymes E and E 2 defined above are marketed by the company SIGMA.
L'immobilisation des enzymes sur la membrane s'opère de la façon suivante :The immobilization of the enzymes on the membrane operates as follows:
Les membranes se présentent sous la forme de disques de 5 cm de diamètre que l'on active à l'aide d'une solution d'acide sulflirique dans le méthanol sous reflux pendantThe membranes are in the form of discs of 5 cm in diameter which are activated using a solution of sulfliric acid in methanol under reflux for
6 heures. On les soumet ensuite à l'action d'une solution de glutaraldéhyde à 2 %6 hours. They are then subjected to the action of a 2% glutaraldehyde solution
V/V, comme décrit dans l'article de Michalon, P., Couturier, R., Hacques, M-F.,V / V, as described in the article by Michalon, P., Couturier, R., Hacques, M-F.,
Favre-Bonvin, G, Ville, A. & Marion, C. (1990) Biochem. Biophys. Res. Commun,Favre-Bonvin, G, Ville, A. & Marion, C. (1990) Biochem. Biophys. Res. Common,
167, 9-15. Le greffage des enzymes E, = GK et E2 = phosphatase alcaline est réalisé en immergeant les disques à température ambiante pendant 3 heures dans 5 cm3 d'une solution d'enzyme titrant 2 mg. cm-3 et 0,2 mg. cm-3 pour la GK et la phosphatase respectivement, dans un tampon borate 0,1 M, pH 8,5.167, 9-15. The grafting of enzymes E, = GK and E 2 = alkaline phosphatase is carried out by immersing the discs at room temperature for 3 hours in 5 cm 3 of an enzyme solution titrating 2 mg. cm -3 and 0.2 mg. cm -3 for GK and phosphatase respectively, in 0.1 M borate buffer, pH 8.5.
Le volume de Cj = 4 cm3 et le volume de Cπ = 300 cm3. 1.2. Conditions opératoiresThe volume of C j = 4 cm3 and the volume of C π = 300 cm3. 1.2. Operating conditions
Les milieux liquides en Cj et Cπ ont la même composition à l'exception des concentrations en composé A = glycérol-3 -phosphate2- et en composé B = glycérol. La température du milieu liquide est thermostatée par la cuve à 25 ° C.The liquid media in C j and C π have the same composition with the exception of the concentrations of compound A = glycerol-3-phosphate 2- and of compound B = glycerol. The temperature of the liquid medium is thermostatically controlled by the tank at 25 ° C.
Les autres conditions opératoires varient en fonction des essais réalisés.The other operating conditions vary according to the tests carried out.
1.3. Essais 1 à 3 selon la 1ère voie enzymatique de la Fig. 2 :1.3. Tests 1 to 3 according to the 1st enzymatic route of FIG. 2:
E membrane E, (Cι) A → B » B >A (C„) Pour ces essais 1 à 3, les milieux liquides C,/Cπ contiennent du tampon borate 0,1 M en quantité telle que le pH soit de l'ordre de 9 et de l'ATP Mg Cl2 - 7 mM. A pH 9, la résistance électrique de la membrane vis-à-vis du substrat A (r ψ A), qui s'ajoute à la résistance passive de la membrane vis-à-vis de la diffusion du substrat A dans le compartiment Cπ (RmA), est de l'ordre de 300 min.cm-3. Les conditions d'agitation sont les suivantes : Wj = 70 tr/min (compartiment I) W2 = 80 tr/min (compartiment II).E membrane E, (Cι) A → B »B> A (C„) For these tests 1 to 3, the liquid media C, / C π contain 0.1 M borate buffer in an amount such that the pH is l '' of 9 and ATP Mg Cl 2 - 7 mM. At pH 9, the electrical resistance of the membrane vis-à-vis the substrate A (r ψ A), which is added to the passive resistance of the membrane vis-à-vis the diffusion of the substrate A in compartment C π (RmA), is around 300 min.cm -3 . The stirring conditions are as follows: W j = 70 rpm (compartment I) W 2 = 80 rpm (compartment II).
Dans ces conditions, les couches de diffusion δ, et δ2 sont respectivement de 100 μm et 150 μm.Under these conditions, the diffusion layers δ, and δ 2 are respectively 100 μm and 150 μm.
Les concentrations initiales sont les suivantes : Essai 1 :
Figure imgf000024_0001
= 0,6 mM , Bb0 = Ab, 0 = Bb, t = 0 pompage enzymatique voie 1 Essai 2 :
Figure imgf000024_0002
= 0,7 mM , Ab0 = Bb, 0 = Ab, t = 0 Translocation de B = glycérol de C, vers Cπ avec transformation
The initial concentrations are as follows: Test 1:
Figure imgf000024_0001
= 0.6 mM, B b0 = A b , 0 = B b , t = 0 enzymatic pumping channel 1 Test 2:
Figure imgf000024_0002
= 0.7 mM, A b0 = B b , 0 = A b , t = 0 Translocation of B = glycerol from C, to C π with transformation
B E1 v 2 A = G3P2 Essai 3 : A l 0 ≈ 0,6 mM , Bb I10 = 0,7 mM,
Figure imgf000024_0003
pompage enzymatique voie 1 + translocation analogue à celle de l'essai 2. Dans ces essais, on mesure en continu les concentrations Ab π 0 , Bb π 0 , Bb, 0 → Ab n t , Bb,j t , Bb, , à l'aide d'analyseurs à électrodes ampérométriques.
B E 1 v 2 A = G3P 2 Test 3: A l 0 ≈ 0.6 mM, B b I10 = 0.7 mM,
Figure imgf000024_0003
enzymatic pumping channel 1 + translocation similar to that of test 2. In these tests, the concentrations A b π 0 , B b π 0 , B b , 0 → A b nt , B b , jt , B are continuously measured b ,, using analyzers with amperometric electrodes.
Les Figures 6, 7 et 8 annexées sont des graphes donnant l'évolution des concentrations en G3P2- et Glycérol dans les compartiments C, et C,,, pour les essais 1 à 3 respectivement.Figures 6, 7 and 8 appended are graphs showing the evolution of the concentrations of G3P 2- and Glycerol in compartments C, and C ,,, for tests 1 to 3 respectively.
La Figure 6 montre clairement la surconcentration du G3P 2-(A) dans C,, obtenue par transport actif transmembranaire de Glycérol (B), jouant le rôle d'intermédiaire E migrateur et issu de la transformation A ' B dans Cπ. La translocation (essai 2) combinée au pompage enzymatique (essai 1) permet d'améliorer encore la surconcentration en A (G3P2-) dans C, (essai 3).Figure 6 clearly shows the over-concentration of G3P 2- (A) in C ,, obtained by active transmembrane transport of Glycerol (B), acting as an intermediary E migratory and resulting from the transformation A ' B in C π . The translocation (test 2) combined with the enzymatic pumping (test 1) makes it possible to further improve the over-concentration in A (G3P 2- ) in C, (test 3).
EXEMPLE II : Séparation/surconcentration de glycérol 3-phosphate2-et de glycérol dans C,, en mettant en oeuvre les voies enzymatiques 1 et 2, (Fig.2 et 3) respectivement, avec la même méthodologie que celle utilisée dans l'exemple 1.EXAMPLE II: Separation / over-concentration of glycerol 3-phosphate 2- and glycerol in C ,, by using the enzymatic pathways 1 and 2, (FIGS. 2 and 3) respectively, with the same methodology as that used in example 1.
2. 1. Matériel2. 1. Material
Le dispositif mis en oeuvre est celui décrit supra et représenté sur la Fig. 1. Pour la description des membranes et des enzymes, on se référera au pointThe device used is that described above and shown in FIG. 1. For the description of membranes and enzymes, reference is made to the point
1.1. supra.1.1. supra.
2.2. Conditions opératoires2.2. Operating conditions
Les milieux liquides en C, et Cπ ont la même composition, à l'exception des concentrations en composé A = glycérol-3-phosphate2- et en composé B = glycérol. La température du milieu liquide est thermostatée par la cuve à 25 ° C. Les autres conditions opératoires varient en fonction des essais réalisés.The liquid media in C and C π have the same composition, with the exception of the concentrations of compound A = glycerol-3-phosphate 2- and of compound B = glycerol. The temperature of the liquid medium is thermostatically controlled by the tank at 25 ° C. The other operating conditions vary depending on the tests carried out.
2.3. Essais 4 à 6 : Voie 1 Transport de A de Cn dans C, membrane E,2.3. Tests 4 to 6: Channel 1 Transport of A from C n into C, membrane E,
(Ci) AB B — *A (C">(Ci) ABB - * A (C ">
La configuration de membrane enzymatique est la même que celle de l'exemple 1, la membrane est électriquement chargée de telle sorte que : r ψ A = résistance électrique de la membrane vis-à-vis de A = + 300 min. cm-3. r ψ B = résistance électrique de la membrane vis-à-vis de B = 0.The configuration of the enzymatic membrane is the same as that of Example 1, the membrane is electrically charged so that: r ψ A = electrical resistance of the membrane with respect to A = + 300 min. cm -3 . r ψ B = electrical resistance of the membrane against B = 0.
Les coefficents de diffusion de A et B au travers de la membrane sont les suivants :The diffusion coefficients of A and B across the membrane are as follows:
DA = 4,09 10-4 cm .min-1. DB = 5,05.10-4 cm2.min-1.D A = 4.09 10 -4 cm .min -1 . D B = 5.05.10 -4 cm 2 .min- 1 .
Les constantes de vitesse du 1er ordre vis-à-vis de A pour E E2, sont : k, = 3,4 cm3, min-1 k2 = 0,6 cm3. min-1 l'épaisseur de la membrane d = 2,4.10-2cm La surface de pore de la membrane est Aw = 0,38cm2. La surface de la membrane est A = 3,14 cm2.The 1st order speed constants with respect to A for EE 2 , are: k, = 3.4 cm 3 , min -1 k 2 = 0.6 cm 3 . min -1 the thickness of the membrane d = 2,4.10 -2 cm The pore surface of the membrane is Aw = 0.38 cm 2 . The surface of the membrane is A = 3.14 cm 2 .
Les volumes de C,/Cπ sont Vt = 4 cm3 et V2 = 300 cm3. δl = 1.10-2 cm δ2 = l,5.10- cm.The volumes of C, / C π are V t = 4 cm 3 and V 2 = 300 cm 3 . δl = 1.10 -2 cm δ2 = l, 5.10- cm.
Dans les. essais 4 à 6, les concentrations initiales et finales (mol. cm-3) en A et B donc C,, Cπ sont données dans le Tableau 1 ci-dessous : Tableau 1In the. tests 4 to 6, the initial and final concentrations (mol. cm -3 ) in A and B therefore C ,, C π are given in Table 1 below: Table 1
Figure imgf000026_0001
Figure imgf000026_0001
5 = translocation de B de C,, en A dans C,.5 = translocation of B from C ,, to A in C ,.
6 = 4 + 5.6 = 4 + 5.
-> Essais 7 à 9 : transport de B de Cπ dans C, : Voie 2-> Tests 7 to 9: transport of B from C π into C,: Path 2
Ce sont les mêmes conditions que pour les essais 4 à 6 sauf en ce qui concerne r ψ A et r ψ B. c membrane E„These are the same conditions as for tests 4 to 6 except with regard to r ψ A and r ψ B. c membrane E „
- A - B (C,)- A - B (C,)
(Cn) B - A(Cn) B - A
Toutes choses égales par ailleurs, la configuration de cette voie 2 diffère de celle selon la voie 1 (essais 4 à 6), en ce que :All other things being equal, the configuration of channel 2 differs from that according to channel 1 (tests 4 to 6), in that:
E, est dans la face de la membrane en regard de Cπ et E2 dans celle en regard de C,. Les concentrations (mol. cm-3) initiales et finales mesurées en B et A dans Cπ et C, sont données dans le Tableau 2 : Tableau 2E, is in the face of the membrane opposite C π and E 2 in that facing C ,. The initial and final concentrations (mol. Cm -3 ) measured in B and A in C π and C, are given in Table 2: Table 2
Figure imgf000027_0001
Figure imgf000027_0001
7 = pompage enzymatique de B de Cπ dans C,7 = enzymatic pumping of B from C π into C,
8 = translocation de A de C„ en B dans C,. 9 = 7 + 8.8 = translocation of A from C „to B in C ,. 9 = 7 + 8.
EXEMPLE III : Séparation/surconcentration de glycérol 3-p2- d'un compartiment C, par pompage enzymatique selon le deuxième mode de mise en oeuvre du procédé de l'invention et à l'aide du dispositif de l'invention dans sa deuxième forme de réalisationEXAMPLE III Separation / over-concentration of 3-p 2- glycerol from a compartment C, by enzymatic pumping according to the second embodiment of the method of the invention and using the device of the invention in its second embodiment
3. 1. Matériel3. 1. Material
Le dispositif mis en oeuvre est celui décrit supra et représenté sur la Fig. 4.The device used is that described above and shown in FIG. 4.
Le faisceau 14 est constitué de 88 fibres 13 creuses en cellulose régénéréeBundle 14 is made up of 88 hollow fibers 13 made of regenerated cellulose
(spectra / Por®) de 25 cm de long, soit au total 2200 cm de longueur de fibres. Le seuil de coupure de la paroi de ces fibres 13 qui forme la membrane enzymatique, est de 6 000 D (90 % molécules de PM = 6000 D sont retenues) D diamètre d'une fibre =(spectra / Por ® ) 25 cm long, totaling 2200 cm in fiber length. The cutoff threshold of the wall of these fibers 13 which forms the enzymatic membrane is 6,000 D (90% molecules of PM = 6000 D are retained) D diameter of a fiber =
240 μm, d = 40 μm.240 μm, d = 40 μm.
Le volume interne total du faisceau = 1 ml. A (surface totale) = 166 cm2. La porosité est de 12 %, soit une surface active de transfert de Aw = 20 cm2. Les enzymes : E2 = phosphatase alcalineThe total internal volume of the beam = 1 ml. A (total area) = 166 cm 2 . The porosity is 12%, i.e. an active transfer surface of Aw = 20 cm 2 . Enzymes: E 2 = alkaline phosphatase
E, = glycérol kinase. Ces enzymes sont de même nature que celles des exemples I et II. Le greffage de Ej sur la face interne de la paroi des fibres 13 s'opère comme suit : L'intérieur des fibres est hydrolyse par remplissage avec du KOH 0,1 M pendant 24 heures. Le KOH sert à désestérifier. Les fibres sont ensuite rincées à l'eau distillée. Puis elles sont remplies avec du périodate de sodium 0,25 M, à l'obscurité, pendant des périodes de temps variables. A l'issue de l'incubation, elles sont rincés à l'eau distillée, pour éliminer l'excès de périodate. Les fibres sont alors remplies d'urée à 15 % (p/v) à laquelle est ajoutée de l'acide sulflirique à 0,9 % (v/v). Le tout est incubé dans un bain-marie à 45° C. Les fibres sont alors lavés jusqu'à ce que l'eau de rinçage soit neutre puis mises à incuber 16 heures dans un bain-marie à 45° C avec une agitation constante dans du formaldéhyde 12,5 % (v/v) avec du tampon phosphate 0, IM pH7,5. L'excès de formaldéhyde est éliminé par rinçage à l'eau distillée.E, = glycerol kinase. These enzymes are of the same nature as those of Examples I and II. The grafting of E j on the internal face of the wall of the fibers 13 takes place as follows: The interior of the fibers is hydrolyzed by filling with 0.1 M KOH for 24 hours. The KOH is used to de-esterify. The fibers are then rinsed with distilled water. Then they are filled with 0.25 M sodium periodate, in the dark, for varying periods of time. At the end of the incubation, they are rinsed with distilled water, to remove the excess periodate. The fibers are then filled with 15% (w / v) urea to which is added 0.9% (v / v) sulfliric acid. The whole is incubated in a water bath at 45 ° C. The fibers are then washed until the rinsing water is neutral and then incubated for 16 hours in a water bath at 45 ° C with constant shaking. in formaldehyde 12.5% (v / v) with phosphate buffer 0, IM pH7.5. The excess formaldehyde is removed by rinsing with distilled water.
On fixe alors E, à l'intérieur des fibres, cette dernière étant mise à une concentration de 1 mg.ml-1, dans du tampon phosphate 0,1 M pH7,5. L'incubation dure environ 24 heures, avec une agitation douce. Les fibres sont alors rincées à l'eau distillée puis mis dans du KCl IM pendant 15 minutes avec une agitation douce. Elles sont de nouveau rincées, puis remises 15 minutes dans du KCl IM et rincées une dernière fois.E is then fixed inside the fibers, the latter being brought to a concentration of 1 mg.ml -1 , in 0.1 M phosphate buffer pH7.5. The incubation lasts about 24 hours, with gentle shaking. The fibers are then rinsed with distilled water and then put in KCl IM for 15 minutes with gentle stirring. They are rinsed again, then put back for 15 minutes in KCl IM and rinsed one last time.
On reproduit les mêmes étapes pour le greffage de E2 à l'extérieur des fibres, qui ne sont cette fois plus remplies mais immergées. Les caractéristiques de fibres greffées avec E, et E2, sont les suivantes : Ej et E2 activité de 25 n mol. min-1 cm-1 de longueur de fibre, soit 25.10-9 mol. min-1 x 2200 cm = 55.106 mol.min-1 The same steps are reproduced for grafting E 2 outside the fibers, which are no longer filled but submerged. The characteristics of fibers grafted with E and E 2 are as follows: E j and E 2 activity of 25 n mol. min -1 cm -1 of fiber length, i.e. 25.10 -9 mol. min -1 x 2200 cm = 55.10 6 mol.min -1
* E2 = phosphatase alcaline (Km = 6.10-6 mol.cm-3) (k = Vm/Km) k2 = 55.10-6 /6.10-6 = 9,l cm3 min-1.* E 2 = alkaline phosphatase (Km = 6.10 -6 mol.cm -3 ) (k = Vm / Km) k 2 = 55.10- 6 /6.10 -6 = 9, l cm 3 min -1 .
* E, = glycérol kinase (Km = 7.10-8 mol.cm-3) (k! = 55.10-6 /7.10-8 = 785 cm3.min-1).* E, = glycerol kinase (Km = 7.10 -8 mol.cm -3 ) (k ! = 55.10 -6 /7.10 -8 = 785 cm 3 .min -1 ).
DA = 5,05.10-4 cm2.min 1. DB = 4,09.10-4 cm2.min-1. * δ2 = 150 μm = l,5.10-2 cm. * δ, = 10 μm = 1.10- cm. * V, = 0,83 ml (en retranchant le volume correspondant à δ,). 3.2. Essais 10 à 12 : Variation charge membrane enzymatique tubulaire transport actif de :D A = 5.05.10 -4 cm 2 .min 1 . D B = 4,09.10- 4 cm 2 .min -1 . * δ 2 = 150 μm = l, 5.10 -2 cm. * δ, = 10 μm = 1.10- cm. * V, = 0.83 ml (by subtracting the volume corresponding to δ,). 3.2. Tests 10 to 12: Variation in the tubular enzymatic membrane load active transport of:
(n) (I) membrane E1 (n) (I) membrane E 1
, . -. A -→ B B A (C„) . . . „, extérieur fibres "' intérieur fibres. Pour ces essais, les paramètres expérimentaux sont les suivants : k, = 7,85 x 102 cm3 x min-1 k2 = 9,l cm3. min-1. d = 4.10-3 cm,. -. A - → BBA (C „). . . „, Outside fibers"'inside fibers. For these tests, the experimental parameters are as follows: k, = 7.85 x 10 2 cm 3 x min -1 k 2 = 9, l cm 3. Min -1 . D = 4.10- 3 cm
Aw = 20 cm2 A = 166 cm2 δ, = 1.10-3 cmAw = 20 cm 2 A = 166 cm 2 δ, = 1.10 -3 cm
DA = 4,09 x lO-4 cm2.min-1.D A = 4.09 x 10 -4 cm 2 .min -1 .
DB = 5,05 .10-4 cm .min-1.D B = 5.05 .10- 4 cm .min -1 .
V, = 0,83 cm3 δ2= l,5.10-2 cm rΨA = 2 min. cm-3 essai 10 5 min. cm-3 essai 10 10 min. cm-3 essai 12 rΨB = 0 min. cm-3 Les concentrations (mol x cm-3) en A (G3P-2) et en B (Glycérol) dans le Cπ (cuve 11) et le C, (lumière fibres immergées) sont données dans le Tableau 3 ci-après p.27V, = 0.83 cm 3 δ 2 = l, 5.10 -2 cm rΨ A = 2 min. cm -3 test 10 5 min. cm -3 test 10 10 min. cm -3 test 12 rΨ B = 0 min. cm -3 The concentrations (mol x cm -3 ) of A (G3P -2 ) and B (Glycerol) in C π (tank 11) and C, (light immersed fibers) are given in Table 3 below. after p.27
La Figure 9 annexée rend également compte de ces résultatsFigure 9 attached also reports these results.
3.3. Essais 13 à 1 - Variation charge membranaire * transport actif A(C„) → A (C,) * + translocation B(Cπ) → A (C,)3.3. Tests 13 to 1 - Variation in membrane charge * active transport A (C „) → A (C,) * + translocation B (C π ) → A (C,)
Les paramètres sont identiques à ceux des essais 10 à 12.The parameters are identical to those of tests 10 to 12.
Les résultats sont donnés par le Tableau 4 ci-après p.28.The results are given in Table 4 below on p.28.
La Figure 10 annexée rend également compte de ces résultats. EXEMPLE IV : Séparation/surconcentration de glycérol (B) d'un compartiment Cπ vers un compartiment C, par pompage enzymatique selon le deuxième mode de mise en oeuvre du procédé de l'invention et à l'aide du dispositif de l'invention dans sa deuxième forme de réalisation 4. 1. Matériel et conditions expérimentalesFigure 10 attached also reports these results. EXAMPLE IV: Separation / over-concentration of glycerol (B) from a compartment C π to a compartment C, by enzymatic pumping according to the second embodiment of the process of the invention and using the device of the invention in its second embodiment 4. 1. Material and experimental conditions
Le dispositif mis en oeuvre est le même que celui de l' exemple 3, à la différence que, E2 est greffée à l'intérieur des fibres 13 et E{ à l'extérieur. Les conditions expérimentales sont les mêmes qu'à l'exemple 3, à l'exception des paramètres suivants : k, = 9, 1 cm3 min-1.The device used is the same as that of Example 3, with the difference that, E 2 is grafted inside the fibers 13 and E { outside. The experimental conditions are the same as in Example 3, with the exception of the following parameters: k, = 9.1 cm 3 min -1 .
7,85.102 cm3.min-».7.85.10 2 cm 3 .min- ".
DB = 5,05.10-4 cm2.min-1. DA = 4,09.10-4 cm2.min-1. rΨB = 0 min.cm-3A = variable.D B = 5.05.10 -4 cm 2 .min -1 . D A = 4,09.10- 4 cm 2 .min -1 . rΨ B = 0 min.cm -3A = variable.
4.2. Essais 15 à 17 : Variation charge et porosité membrane tubulaire transport actif B de Cπ vers C, : essai 15 : Aw = 20cm2 et rΨA = - 0,4 min.cm-3 essai 16 : Aw = 20cm2 et rΨA = - 0,48 min.cm 3 essai 17 : Aw = 2cm2 et rΨA = - 0,48 min.cm-3
Figure imgf000030_0001
4.2. Tests 15 to 17: Variation in load and porosity of the tubular membrane active transport B from C π to C,: test 15: Aw = 20cm 2 and rΨ A = - 0.4 min.cm -3 test 16: Aw = 20cm 2 and rΨ A = - 0.48 min.cm 3 test 17: Aw = 2cm 2 and rΨ A = - 0.48 min.cm- 3
Figure imgf000030_0001
Les résultats sont donnés dans le Tableau 5 ci-après p.29.The results are given in Table 5 below p.29.
4.3. Essais 18 à 20 - Variation charge et porosité membranes tubulaires enzymatique : transport actif B(Cπ) → B (Cr) + translocation A(Cn) → BA (C,)4.3. Tests 18 to 20 - Load and porosity variation in enzymatic tubular membranes: active transport B (C π ) → B (C r ) + translocation A (Cn) → BA (C,)
Ce sont les mêmes conditions que dans les essais 15 à 17. Bb I 0 = 0. Les résultats sont donnés dans le Tableau 6 ci-après p.30. Ces résultats sont donnés également par la Figure 11. Tableau 3These are the same conditions as in tests 15 to 17. B b I 0 = 0. The results are given in Table 6 below p.30. These results are also given in Figure 11. Table 3
Figure imgf000031_0001
Figure imgf000031_0001
Tableau 4Table 4
Figure imgf000032_0001
Figure imgf000032_0001
Tableau 5Table 5
Figure imgf000033_0001
Figure imgf000033_0001
Tableau 6Table 6
Figure imgf000034_0002
Figure imgf000034_0002

Claims

REVENDICATIONS :CLAIMS:
1 - Procédé de séparation et de concentration d'au moins un Produit à Concentrer (Pac), présent dans un milieu liquide sous forme solubilisée, caractérisé en ce qu'il consiste essentiellement et successivement ou non : - à sélectionner au moins un couple d'enzymes réversibles E,/E2,1 - Process for the separation and concentration of at least one Concentrated Product (PAC), present in a liquid medium in solubilized form, characterized in that it consists essentially and successively or not: - of selecting at least one pair d 'reversible enzymes E, / E 2 ,
E, étant apte à catalyser la réaction de transformation d'au moins un substrat A en au moins un produit B et E2 la réaction inverse de transformation du (ou des) substrat(s) B en au moins un produit A :E, being capable of catalyzing the reaction of transformation of at least one substrate A into at least one product B and E 2 the reverse reaction of transformation of the substrate (s) B into at least one product A:
A — B E2 de telle sorteA - B E 2 so
* que A ou B corresponde à Pac* whether A or B corresponds to Pac
* et qu'au moins l'un des composés A ou B soit électriquement chargé, - à prévoir au moins une membrane poreuse comprenant Ej et E2, respectivement, sur et/ou dans l'une et l'autre de ses faces, à immerger la (ou les) membrane(s) poreuse(s) dans le milieu liquide, chaque membrane délimitant au moins en partie au moins un compartiment liquide C, et au moins un compartiment liquide Cπ, à mettre en mouvement au moins l'un des liquides - de préférence les liquides - des compartiments C,/Cπ, en prévoyant au moins une couche de diffusion non-turbulente, attenante à l'une des faces de la ou des membranes, de préférence une couche de diffusion attenante à chaque face de la ou des membranes, à fixer les conditions opératoires de telle sorte qu'intervienne : .1. dans le compartiment C, ou Cπ de départ, au moins une transformation enzymatique par El ou E2, du composé Pac de départ correspondant à A ou B, en métabolite B ou A respectivement selon le cas :* and that at least one of the compounds A or B is electrically charged, - to provide at least one porous membrane comprising E j and E 2 , respectively, on and / or in one and the other of its faces , immersing the porous membrane (s) in the liquid medium, each membrane defining at least in part at least one liquid compartment C, and at least one liquid compartment C π , to set in motion at least one of the liquids - preferably liquids - from compartments C, / C π , by providing at least one non-turbulent diffusion layer, adjoining one of the faces of the membrane (s), preferably a diffusion layer adjoining each side of the membrane (s), fix the operating conditions so that: .1. in compartment C, or starting C π , at least one enzymatic transformation with E l or E 2 , of the compound Pac start corresponding to A or B, in metabolite B or A respectively as appropriate:
Figure imgf000036_0001
Figure imgf000036_0001
.2. la migration du Pac métabolisé par E, ou E2 (intermédiaire migrateur) au travers des pores de la membrane pour passer d'un compartiment C, ou Cπ à l'autre Cπ ou C,, cette migration intervenant notamment sous l'effet d'un gradient de concentration, avec les conditions selon lesquelles :.2. the migration of the Pac metabolized by E, or E 2 (migratory intermediate) through the pores of the membrane to pass from a compartment C, or C π to the other C π or C ,, this migration occurring in particular under the effect of a concentration gradient, with the conditions under which:
• si l'intermédiaire migrateur est un composé A ou B électriquement chargé, alors chaque membrane est chargée du signe opposé sur au moins l'une de ses faces, de préférence celle adjacente à la face portant l'enzyme ayant transformé le Pac,If the migrating intermediate is an electrically charged compound A or B, then each membrane is charged with the opposite sign on at least one of its faces, preferably the one adjacent to the face carrying the enzyme having transformed the Pac,
• et si l'intermédiaire migrateur est un composé A ou B électriquement neutre alors chaque membrane est chargée électriquement du même signe que l'autre composé A ou B non métabolisé et non migrateur (Pac),• and if the migrating intermediary is an electrically neutral compound A or B then each membrane is electrically charged with the same sign as the other non-metabolized and non-migrating compound A or B (Pac),
.3. puis au moins une transformation enzymatique inverse, par E2 ou E,, de l'intermédiaire migrateur (B ou A), en Pac de départ, de telle façon que ce dernier s'accumule et se concentre dans le compartiment Cπ ou C, d'arrivée, à récupérer le Pac ainsi accumulé et surconcentré..3. then at least one reverse enzymatic transformation, by E 2 or E ,, of the migrating intermediate (B or A), into the starting Pac, so that the latter accumulates and is concentrated in the compartment C π or C , of arrival, to recover the Pac thus accumulated and over-concentrated.
2 - Procédé selon la revendication 1, caractérisé en ce que la membrane enzymatique se présente sous la forme d'un film mono ou multicouche, de préférence sensiblement plan.2 - Process according to claim 1, characterized in that the enzymatic membrane is in the form of a monolayer or multilayer film, preferably substantially planar.
3 - Procédé selon la revendication 1, caractérisé en ce que la membrane enzymatique constitue tout ou partie de la paroi d'au moins un tube dont la lumière forme l'un des compartiments C,/Cπ, en ce que l'on fait baigner au moins une partie de cette membrane tubulaire dans le milieu liquide formant l'autre compartiment Cπ/C,, en ce que l'on fait circuler un liquide à enrichir ou à appauvrir en composé Pac, dans cette ou ces membranes enzymatiques tubulaires, de préférence réunies en au moins un faisceau.3 - Method according to claim 1, characterized in that the enzymatic membrane constitutes all or part of the wall of at least one tube whose lumen forms one of the compartments C, / C π , in that one does bathe at least part of this tubular membrane in the liquid medium forming the other compartment C π / C ,, in that a liquid to be enriched or depleted in compound Pac is circulated in this or these tubular enzymatic membranes, preferably combined in at least one bundle.
4 - Procédé selon l'une quelconque des revendications 1 à 3, caractérisé en ce que l'on élabore donc le milieu liquide de C, et/ou Cπ en ayant recours à un solvant - de préférence essentiellement aqueux -, comprenant éventuellement des solutés choisis dans le groupe suivant : o tampons de pH adaptés aux pH optimum de fonctionnement de
Figure imgf000037_0001
o molécules à liaisons riches en énergie - avantageusement ATP ou toute molécule susceptible de transférer un groupement phosphate sur un soluté (par exemple : phosphoénol pyruvate, carbamyl phosphate, phosphocréatine...) o et leurs mélanges, les compositions de départ des milieux liquides de C, et Cπ étant, de préférence, sensiblement les mêmes ou non de la concentration en Pac. les compositions de départ des milieux liquides de C, et C,, étant, de préférence, sensiblement les mêmes, à l'exception de la concentration en Pac.
4 - Method according to any one of claims 1 to 3, characterized in that one therefore develops the liquid medium of C, and / or C π using a solvent - preferably essentially aqueous -, optionally comprising solutes selected from the following group: o pH buffers adapted to the optimum operating pH of
Figure imgf000037_0001
o molecules with energy-rich bonds - advantageously ATP or any molecule capable of transferring a phosphate group onto a solute (for example: phosphoenol pyruvate, carbamyl phosphate, phosphocreatine ...) o and their mixtures, the starting compositions of liquid media of C, and C π being, preferably, substantially the same or not of the Pac concentration. the starting compositions of the liquid media of C, and C ,, being preferably substantially the same, with the exception of the concentration of Pac.
5 - Procédé selon l'une quelconque des revendications 1 à 4, caractérisé en ce que l'on fait en sorte que le compartiment C,/Cπ récepteur de l'intermédiaire migrateur au travers de la membrane, comprenne au départ une concentration en cet intermédiaire, inférieure à celle existant dans le compartiment émetteur.5 - Method according to any one of claims 1 to 4, characterized in that one makes sure that the compartment C, / C π receptor for the migratory intermediate through the membrane, initially includes a concentration of this intermediary, lower than that existing in the issuing compartment.
6 - Procédé selon l'une quelconque des revendications 1 à 5, caractérisé en ce que l'on ajuste les paramètres pH et température des milieux liquides de manière à obtenir un optima en cinétique et en rendement pour les transformations enzymatiques par E, et E2.6 - Process according to any one of claims 1 to 5, characterized in that the pH and temperature parameters of the liquid media are adjusted so as to obtain an optimum in kinetics and in yield for the enzymatic transformations by E, and E 2 .
7 - Procédé selon l'une quelconque des revendications 1 à 6, caractérisé en ce que l'on met en mouvement le liquide de chaque compartiment C,/Cπ, cette mise en mouvement s' opérant par agitation et/ou par circulation du liquide, en ce que l'on règle les conditions d'agitation et/ou de circulation de façon à ce que la ou les couches de diffusion non turbulentes, aient une épaisseur identique ou différente de part et d'autre de la membrane et comprise entre 1 et 10 fois l'épaisseur de la membrane.7 - A method according to any one of claims 1 to 6, characterized in that one sets in motion the liquid of each compartment C, / C π , this setting in motion operating by stirring and / or by circulation of liquid, in that the stirring and / or circulation conditions are adjusted so that the non-turbulent diffusion layer (s) have an identical or different thickness from on either side of the membrane and between 1 and 10 times the thickness of the membrane.
8 - Procédé selon l'une quelconque des revendications 1 à 7, caractérisé en ce que l'on a recours à des moyens d'assistance de la migration transmembranaire de (ou des) intermédiaire(s) migrateur(s), lesdits moyens étant de préférence constitués par un gradient de force ionique et/ou électrique, de part et d'autre de la membrane, et plus préférentiellement encore des gradients de pH (force protomotrice).8 - Method according to any one of claims 1 to 7, characterized in that recourse is made to assistance means for transmembrane migration of (or of) migratory intermediary (ies), said means being preferably constituted by an ionic and / or electric force gradient, on either side of the membrane, and more preferably still pH gradients (protomotor force).
9 - Procédé selon l'une quelconque des revendications 1 à 8, caractérisé en ce que l'on complète la surconcentration du Pac, par pompage enzymatique dudit9 - Method according to any one of claims 1 to 8, characterized in that one supplements the over-concentration of Pac, by enzymatic pumping of said
Pac au travers de la ou des membranes, à partir d'un compartiment C, ou Cπ contenant du Pac vers un compartiment C„ ou C, à enrichir en Pac, par mise en oeuvre d'une translocation du Pac, cette dernière consistant à introduire dans le compartiment C, ou Cπ de départ chargé en Pac, de l'intermédiaire migrateur A ou B, de telle sorte que cet intermédiaire migrateur ajouté migre cumulativement à celui issu de l'étape - 1 -, dans les mêmes conditions que celles de l'étape - 2 -, pour être enfin soumis, à l'étape - 3 - après avoir traversé la membrane, les étapes - 1 -, - 2 -, et - 3 - en cause étant celles telles que définies dans la revendication 1. 10 - Dispositif de séparation et de concentration d'au moins un Produit àPac through the membrane (s), from a compartment C, or C π containing Pac to a compartment C „or C, to be enriched in Pac, by implementing a translocation of the Pac, the latter consisting to be introduced into compartment C, or C π of departure loaded with Pac, of the migratory intermediate A or B, so that this added migratory intermediate migrates cumulatively to that resulting from stage - 1 -, under the same conditions than those of step - 2 -, to be finally submitted, in step - 3 - after having crossed the membrane, the steps - 1 -, - 2 -, and - 3 - in question being those as defined in claim 1. 10 - Device for separation and concentration of at least one Product to
Concentrer (Pac), présent dans un milieu liquide sous forme solubilisée, notamment pour la mise en oeuvre du procédé selon l'une quelconque des revendications 1 à 9, caractérisé en ce qu'il comprend essentiellement :Concentrate (Pac), present in a liquid medium in dissolved form, in particular for the implementation of the method according to any one of claims 1 to 9, characterized in that it essentially comprises:
- au moins une membrane enzymatique poreuse (5,13), comportant au moins un couple d'enzymes réversibles E,/Ε2, E, étant apte à catalyser la réaction de transformation d'au moins un substrat A en au moins un produit B et E2 la réaction inverse de transformation du (ou des) substrat(s) B en au moins un produit A : A -B E2 de telle sorte- at least one porous enzymatic membrane (5,13), comprising at least one pair of reversible enzymes E, / Ε 2 , E, being able to catalyze the reaction of transformation of at least one substrate A into at least one product B and E 2 the reverse reaction of transformation of the substrate (s) B into at least one product A: A -BE 2 so
* que A ou B corresponde à Pac* whether A or B corresponds to Pac
* et qu'au moins l'un des composés A ou B soit électriquement chargé, E, et E2 étant respectivement supportées par l'une et l'autre des faces de la membrane,* and that at least one of the compounds A or B is electrically charged, E, and E 2 being respectively supported by one and the other of the faces of the membrane,
- au moins un conteneur (2, 11) du milieu liquide dans lequel baigne ou est susceptible de baigner la membrane enzymatique (5, 13) pour délimiter au moins partiellement au moins un compartiment liquide C, et au moins un compartiment liquide Cπ,at least one container (2, 11) of the liquid medium in which bathes or is likely to bathe the enzymatic membrane (5, 13) to delimit at least partially at least one liquid compartment C, and at least one liquid compartment C π ,
- des moyens de mise en mouvement (3, 9, 12, 15) d'au moins l'un des liquides de préférence des liquides des compartiments C,/Cπ,means for setting in motion (3, 9, 12, 15) of at least one of the liquids, preferably liquids from the compartments C, / C π ,
- éventuellement des moyens (2„ 22, 11,, 112) de réglage de la température du milieu liquide.- Possibly means (2 „2 2 , 11 ,, 11 2 ) for adjusting the temperature of the liquid medium.
11 - Dispositif selon la revendication 10, caractérisé en ce que chaque membrane (5, 13) est électriquement chargée, sur au moins l'une de ses faces, de préférence sur celle adjacente à la face portant l'enzyme ayant transformé le Pac, et plus préférentiellement encore sur les deux. 12 - Dispositif selon la revendication 10 ou 11, caractérisé en ce que la membrane enzymatique (5, 13) est une matrice poreuse dans et/ou sur les deux faces de laquelle sont incluses et immobilisées les enzymes E,, E2 respectivement, cette matrice étant formée par au moins un composé macromoléculaire, de préférence choisi parmi les protéines, les polysaccharides les (co)polymères synthétiques et leurs mélanges et/ou alliages, la cellulose et ses dérivés, de même que les (co)polyamides étant particulièrement préférés.11 - Device according to claim 10, characterized in that each membrane (5, 13) is electrically charged, on at least one of its faces, preferably on that adjacent to the face carrying the enzyme having transformed the Pac, and even more preferably on both. 12 - Device according to claim 10 or 11, characterized in that the enzymatic membrane (5, 13) is a porous matrix in and / or on the two faces of which are included and immobilized the enzymes E ,, E 2 respectively, this matrix being formed by at least one macromolecular compound, preferably chosen from proteins, polysaccharides, synthetic (co) polymers and their mixtures and / or alloys, cellulose and its derivatives, as well as (co) polyamides being particularly preferred .
13 - Dispositif selon l'une quelconque des revendications 10 à 12, caractérisé en ce que la membrane enzymatique (5) se présente sous la forme d'un film mono ou multicouche, de préférence sensiblement plan. 14 - Dispositif selon l'une quelconque des revendications 10 à 12, caractérisé en ce que la membrane constitue tout ou partie de la paroi d 'au moins un tube (13) dont la lumière forme l'un des compartiments C,/Cπ.13 - Device according to any one of claims 10 to 12, characterized in that the enzymatic membrane (5) is in the form of a single or multilayer film, preferably substantially planar. 14 - Device according to any one of claims 10 to 12, characterized in that the membrane constitutes all or part of the wall of at least one tube (13) whose lumen forms one of the compartments C, / C π .
15 - Dispositif selon l'une quelconque des revendications 10 à 14, caractérisé en ce que le couple d'enzymes réversibles E,/E2 est choisi principalement parmi les couples d'enzymes ElIE2 permettant l' addition/enlèvement d'un groupement chimique chargé sur un métabolite, de préférence parmi les couples d'enzymes E,/E2 de phosphorylation/déphosphorylation, et plus préférentiellement encore parmi les kinases/phosphatases. 15 - Device according to any one of claims 10 to 14, characterized in that the pair of reversible enzymes E, / E 2 is chosen mainly from the pairs of enzymes E l IE 2 allowing the addition / removal of a chemical group loaded on a metabolite, preferably among the pairs of enzymes E, / E 2 of phosphorylation / dephosphorylation, and more preferably still among kinases / phosphatases.
PCT/FR1997/001936 1996-10-31 1997-10-29 Method for separating and concentrating small molecules using enzymatic membrane pumps: separator/concentrator reactor WO1998018904A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU49526/97A AU4952697A (en) 1996-10-31 1997-10-29 Method for separating and concentrating small molecules using enzymatic membrane pumps: separator/concentrator reactor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9613554A FR2755036B1 (en) 1996-10-31 1996-10-31 PROCESS FOR SEPARATION AND CONCENTRATION OF SMALL MOLECULES USING MEMBRANE ENZYMATIC PUMPS: SEPARATOR / CONCENTRATOR REACTOR
FR96/13554 1996-10-31

Publications (1)

Publication Number Publication Date
WO1998018904A1 true WO1998018904A1 (en) 1998-05-07

Family

ID=9497394

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR1997/001936 WO1998018904A1 (en) 1996-10-31 1997-10-29 Method for separating and concentrating small molecules using enzymatic membrane pumps: separator/concentrator reactor

Country Status (3)

Country Link
AU (1) AU4952697A (en)
FR (1) FR2755036B1 (en)
WO (1) WO1998018904A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777803B1 (en) * 1998-04-24 2000-07-28 Univ Claude Bernard Lyon PROCESS FOR THE ACTIVE AND SELECTIVE REMOVAL OF SMALL MOLECULES BY ENZYMATIC PUMPING: ACTIVE DIALYSIS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273679A2 (en) * 1986-12-29 1988-07-06 EASTMAN KODAK COMPANY (a New Jersey corporation) Improved method for effecting enzymatic reactions and an enzymatic reactor useful therein
US4956289A (en) * 1987-03-16 1990-09-11 Brunswick Corporation Thin film membrane enzyme reactor and method of using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0273679A2 (en) * 1986-12-29 1988-07-06 EASTMAN KODAK COMPANY (a New Jersey corporation) Improved method for effecting enzymatic reactions and an enzymatic reactor useful therein
US4956289A (en) * 1987-03-16 1990-09-11 Brunswick Corporation Thin film membrane enzyme reactor and method of using same

Also Published As

Publication number Publication date
AU4952697A (en) 1998-05-22
FR2755036A1 (en) 1998-04-30
FR2755036B1 (en) 1999-01-22

Similar Documents

Publication Publication Date Title
EP0746406B1 (en) Method for surface-modifying a polymeric membrane, and resulting membrane
FR2682613A1 (en) PROCESS FOR AT LEAST PARTIAL DEHYDRATION OF AN AQUEOUS COMPOSITION AND DEVICES FOR IMPLEMENTING THE METHOD.
EP0187586B1 (en) Process and apparatus for preparative electrophoresis
EP0676145A1 (en) Coffee hydrolysis with immobilised beta-mannanase
FR2714299A1 (en) Affinity separation method, affinity particles and method for bringing these affinity particles to size.
EP0106769A1 (en) Surface-grafted particulate support, its preparation and adsorbents for affinity-chromatography comprising this support, and its use, especially in biology
FR2570715A1 (en) PROCESS FOR CARRYING OUT AN ENZYMATIC OR MICROBIAL REACTION
EP0964737B1 (en) Hollow membranes with capillary tubes, modules for treating fluid using same and methods for making same
BE897926A (en) PROCESS FOR PRODUCING A IMMOBILIZED ENZYME PREPARATION USING A CROSS-LINKING AGENT, PREPARATION OF IMMOBILIZED ENZYME THUS OBTAINED, AND USE THEREOF
FR2609723A1 (en) PROCESS FOR THE PREPARATION OF AN IMMOBILIZED ENZYME OR MICROORGANISM
WO1998018904A1 (en) Method for separating and concentrating small molecules using enzymatic membrane pumps: separator/concentrator reactor
FR2636542A1 (en) BIOCHEMICAL PROCESS, GLASS MICROBALLS AND BIOREACTOR FOR SEPARATING A MATERIAL FROM A FLUID MEDIUM
EP2024103A2 (en) Method for depositing a nanometric thin film on a substrate
FR2777803A1 (en) Dialysis process with enzymatic pumping to increase speed and selectivity for removal of small solutes, particularly removal of glucose from blood
EP1342089A2 (en) Temporary separation barrier, container comprising same and method for carrying out a test in said container
EP0139592A2 (en) Process and apparatus for the production of aminoacids by fermentation
Godjevargova et al. Biodegradation of phenol by immobilized Trichosporon cutaneum R57 on modified polymer membranes
FR2559500A1 (en) CELL CULTURE PROCESS WITH BARBOTAGE OF A GAS
WO2012035268A9 (en) Device and method for crystallising inorganic or organic substances
EP0453473B1 (en) Support for selective immuno-purification of a liquid and process for treating said support
EP0247931A1 (en) Process for the extraction of valuable components from complex solutions, and membrane device for the realization of this process
Liu et al. Constructing biocatalytic nanochannel membranes for unidirectional isomer conversion and separation
JPH0817711B2 (en) Method for separating and concentrating fermentation products
EP1352058A2 (en) Preparation of immobilised acclimated micro-organisms, production method and use for reactivating interrupted fermentation processes
CA1157400A (en) Immobilization process of globular microbial cells by adhesion to a solid carrier

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA